This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literaturverzeichnis
Aarts PAMM, Banga JD, van Houwelingen HC, Heethaar RM, Sixma JJ (1985) Influence of isoxsu-prine on red cell deformability in vivo and effects on platelet adherence in vitro (Abstract). Clin Hemorheol 5: 753.
Aarts PAMM, Banga JD, van Houwelingen HC, Heethaar RM, Sixma JJ (1986) Increased red blood cell deformability due to isoxsuprine administration decreases platelet adherence in a perfusion chamber: A double-blind cross-over study in patients with intermittent claudication. Blood 67: 1474.
Abel JJ, Rowntree LG, Turner BB (1914) Plasma removal with return of the corpuscles. J Pharmacol Exp Ther 5: 625.
Abruzzo JL, Heimer R, Giuliano V, Martinez J (1970) The hyperviscosity syndrome, polysynovitis, polymyositis and an unusual 13 S serum IgG component. Am J Med 49: 258.
Adam H (1909) Zur Viskosität des Blutes. Z Klin Med 68: 177.
Akiyama M, Isogai Y, Yokose T, Okabe M, Ashikaga M, Ikemoto S, Maeda T, Abe M (1981) Changes in hemorheological factors of diabetics during use of artificial pancreas (Abstract). Clin Hemorheol 1: 300.
Albanese B (1983) Modificazioni dell’emoreologia indotte dal farmaco α-litico timoxamina. Ric Clin Lab 13(Suppl 3): 469.
Albers D (1937) Die Viskosität des Blutes in der kardialen Herzinsuffizienz. Z Kreislaufforsch 29: 914.
Albers D (1937) Multiple Myelome und Viscosität. Z Klin Med 132: 807.
Alderman MJ, Ridge A, Morley AA, Ryall RG, Walsh JA (1981) Effect of total leucocyte count on whole blood filterability in patients with peripheral vascular disease. J Clin Pathol 34: 163.
Allan TL (1981) Plasma exchange in macroglobulinaemia. In: Lowe GDO, Barbenel JC, Forbes CD (eds) Clinical aspects of blood viscosity and cell deformability. Springer, Berlin, p235.
Alwall N (1939) Jodtherapie bei Hypertonie und Arteriosklerose. Acta Med Scand 101: 83.
Amtoft A (1973) The effect of Dextran 40 on capillary blood flow and capillary diffusion capacity in the anterior tibial muscle of subjects with intermittent claudication. Scand J Clin Lab Invest 31: 263.
Anadere I, Chmiel H, Witte S (1985) Hemorheological findings in patients with completed stroke and the influence of a ginkgo biloba extract. Clin Hemorheol 5: 411.
Angelkort B (1979) Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease. Curr Med Res Opin 6: 255.
Angelkort B, Boateng K, Maurin N (1980) Blood fluidity and coagulation phenomena in chronic arterial occlusive disease. J Int Med Res 8: 242.
Angelkort B, Kiesewetter H (1981) Influence of risk factors and coagulation phenomena on the fluidity of blood in chronic arterial occlusive disease — Effects of pentoxifylline. Scand J Clin Lab Invest 41(Suppl 156): 185.
Angelkort B, Kiesewetter H, Maurin N (1981) Einfluß von Hämodilution und oraler Pentoxifyllin-Medikation auf Muskeldurchblutung, Fließverhalten und Hämostase des Blutes bei chronischer arterieller Verschlußkrankheit. In: Breddin K (ed) Thrombose und Atherogenese. Pathophysiologic und Therapie der arteriellen Verschlußkrankheit. Bein-Beckenvenen-Thrombose. Witzstrock, Baden-Baden, p 114.
Angelkort B, Frömel M (1981) Influence of hemodilution on fluidity and hemostasis in chronic occlusive arterial disease — Study with high molecular hydroxyethyl starch solution (Abstract). Clin Hemorheol 1: 453.
Angelkort B, Spürk P, Ludwig P (1984) An appraisal of interrelationship between blood fluidity and walking performance in peripheral arterial occlusive disease. IRCS Med Sci 12: 360.
Angelkort B, Spürk P, Habbaba A, Mähder M (1985) Blood flow properties and walking performance in chronic arterial occlusive disease. Angiology 36: 285.
Annoni F, Monti D, Mozzi E, Chiurazzi D, Marincola F (1983) Ciclonicate in patients with chronic occlusive peripheral arterial disease: Haemodynamic and rheologic effects. Acta Ther 9: 29.
4th Annual meeting of Japan Society of Biorheology (1982) (Abstracts). Biorheology 19: 375.
Antignani PL, Todini AR, Saliceti F, Pacino G, Bartolo M (1985) Clinical, instrumental and hemo-rheological effects after acute therapy with pentoxifylline (Abstract). Clin Hemorheol 5: 731.
Apsatarov EA, Goryachev SP, Lyubinsky VL, Timukhina RA, Stakhov OV (1985) Changes of microcirculation and blood rheologic properties in patients with Leriche’s syndrome. Khirurgiia (Mosk) 6: 44.
Arntz HR, Leonhardt H, Dreykluft HR (1979) Influence of Clofibrate on blood viscosity in primary hyperlipoproteinemia. Klin Wochenschr 57: 43.
Arntz HR, Heitz J, Schäfer JH, Zingler G, Schröder R (1985) High-dose intravenous streptokinase (SK) in acute myocardial infarction (AMI): Hemorheological aspects (Abstract). Clin Hemorheol 5: 729.
Aronson HB, Magora F, London M (1970) The influence of droperidol on blood viscosity in man. Br J Anaesth 42: 1089.
Aronson HB, Magora F, Schenker JG (1971) Effect of oral contraceptives on blood viscosity. Am J Obstet Gynecol 110: 997.
Artale F, Sergio G, Di Palma A, Giunti P, Perego MA (1980) Effetto dell’infusione venosa di pentos-sifillina sulla deformabilità eritrocitaria nell’arteriopatia ostruttiva periferica. II Policlinico, Sez Medica 87: 338.
Artale F, Francisci A, Espureo M, Sergio G, Cramarossa L, Di Palma A, Perego MA (1982) Effects of S-adenosyl-L-methionine on hemorheological changes induced by exercise in patients with peripheral occlusive arterial diseases. Curr Ther Res 32: 520.
Aukland A, Hurlow RA, George AJ, Stuart J (1982) Platelet inhibition with ticlopidine in atherosclerotic intermittent claudication. J Clin Pathol 35: 740.
Auteri A, Pieragalli D, Blardi P (1984) Azione della CDP-colina sulla sindrome da iperviscosità ematica secondaria delle vasculopatie croniche ischemizzanti. Minerva Cardioangiol 32: 53.
Avellone G, Pinto A, Mandalà V, Galati D, Di Garbo V, Strano A (1985) Modificazioni emoreologiche indotte dalla somministrazione di buflomedil cloridrato nelle arteriopatie obliteranti degli arti inferiori. Ric Clin Lab 15(Suppl 1): 577.
Ayres ML, Jarrett PEM, Browse NL (1981) Blood viscosity, Raynaud’s phenomenon and the effect of fibrinolytic enhancement. Br J Surg 68: 51.
Azzena D, Costa U, Ghigliotti G, Astengo F (1968) Serum hyperviscosity in multiple myeloma and its clinical and neuropsychiatric implications. Confin Neurol 30: 65.
Bach R, Kiesewetter H, Jung F, Kotitschke G, Witt R, Nüttgens HP, Ladwig KH, Waterloh E, Roebruck P, Gerhards M, Schieffer H, Bette L, Wenzel E (1987) Koronare Herzkrankheit: Prävalenz, Risikofaktoren-Profil und rheologisches Profil. Erste Ergebnisse der Aachen-Studie. In: Strauer BE, Ehrly AM, Leschke M (eds) Fortschritte in der kardiovaskulären Hämorheologie (5.DGKHKongreß, Marburg, 1986). Münchner Wissenschaftliche Publikationen, München, p7.
Bada HS, Korones SB, Kolni HW, Fitch CW, Ford DL, Magill HL, Anderson GD, Wong SP (1986) Partial plasma exchange transfusion improves cerebral hemodynamics in symptomatic neonatal polycythemia. Am J Med Sci 291: 157.
Baer MR, Stein RS, Dessypris EN (1985) Chronic lymphocytic leukemia with hyperleukocytosis. The hyperviscosity syndrome. Cancer 56: 2865.
Bäumler H, Lerche D, Scherf HP, Bilsing R, Meier W, Kucera W, Wiesner S (1982) Experimentelle Untersuchungen zum Theologischen Verhalten von Blut bei Ultraviolettbestrahlung (UVB). Z Ges Inn Med 37: 458.
Balabanova RM, Guseva NG, Apenysheva NP, Oskilko TG, Anikina NV (1983) Effect of reopoly-glucin on the microcirculation of patients with sclerodermia systematica. Revmatologiia (Moskva) 3: 26.
Bapistella B (1972) Untersuchungen über den Einfluß der Streptokinase auf die Blutviskosität und die Aggregation der Erythrozyten. Dissertationsschrift, Frankfurt am Main.
Barnard RJ, Hall JA, Pritikin N (1985) Effects of diet and exercise on blood pressure and viscosity in hypertensive patients. J Cardiac Rehabil 5: 185.
Barnes AJ, Oughton J, Willars EJ, Clark PA, Kohner EM (1983) Effect of o-(β-hydroxyethyl)-rutosides (HR) on blood rheology in normals and diabetic patients (Abstract). Clin Hemorheol 3: 287.
Baron M, Fam AG, Elkan I, Underdown B (1982) Hyperviscosity syndrome in rheumatoid arthritis. J Rheumatol 9: 843.
Barras JP (1969) The capillary flow of suspensions of human red blood cells in plasma substitutes. Bibl Anat 10: 38.
Barras JP, Maibach E (1971) Effect du HR sur la viscosite sanguine dans l’insuffisance veineuse chronique. Abstract-Booklet 4th Int Congr Phlebol, Lucerne, p93.
Barras JP, Graf C (1980) Hyperviscosity in diabetic retinopathy treated with Doxium (calcium do-besilate). Vasa 9: 161.
Barras JP, Graf C (1981) Effects of medication on blood and plasma viscosity in diabetic subjects with retinopathy. Horm Metab Res 13(Suppl 11): 120.
Barras JP, Blattner J (1985) Viscoelastic properties of blood and plasma in diabetes. Vasa 14: 216.
Bartolo M (1985) Emodiluizione, defibrinogenazione e plasmaferesi in emoreologia. Ric Clin Lab 15(Suppl 1): 439.
Baum RS (1967) Hyperviscous blood and perinatal pathology (Abstract). Pediatr Res 1: 288.
Bayliss LE (1960) The anomalous viscosity of blood. In: Copley AL, Stainsby G (eds) Flow properties of blood and other biological systems. Pergamon, London, p 29.
Beck JR, Quinn BM, Meier FA, Rawnsley HM (1982) Hyperviscosity syndrome in paraproteinemia. Managed by plasma exchange; monitored by serum tests. Transfusion 22: 51.
Becker B (1976) Untersuchungen über den Einfluß einiger Medikamente auf die Fließeigenschaften des Blutes. Dissertationsschrift, Frankfurt am Main.
Bedi SS, Eberl R, Million R, Silas AM (1984) Fenclofenac and diclofenac in the treatment of rheumatoid arthritis. Br J Rheumatol 23: 214.
Begg TB, Hearns JB (1966) Components in blood viscosity. The relative contribution of haematocrit, plasma fibrinogen and other proteins. Clin sci 31: 87.
Belch JJF, Lowe GDO, Drummond MM, Forbes CD, Prentice CRM (1981) Prostacyclin reduces red cell deformability (Leserbrief). Thromb Haemost 45: 189.
Benarroch IS, Brodsky M, Rubinstein A, Viggiano C, Salama EA (1985) Treatment of blood hyperviscosity with calcium dobesilate in patients with diabetic retinopathy. Ophthalmic Res 17: 131.
Benda L, Redtenbacher L, Spieß A, Steinbach T (1971) Fibrinolytische Behandlung bei schwerer Angina pectoris. Dtsch Med Wochenschr 96: 771.
Benda L (1972) Streptokinase und Blutviskosität bei akutem Herzinfarkt. In: Sailer S (ed) Aktuelle Probleme der Fibrinolyse-Behandlung. Hollinek, Wien, p 27.
Benda L (1973) Influence of streptokinase on blood rheology and coagulation. Postgrad Med J 49(Suppl 5): 129.
Benda L, Klösel W, Redtenbacher L, Spieß A, Zenz W (1976) Fibrinolyse und Antikoagulation bei schwerer Angina pectoris. Wien Med Wochenschr 126: 1.
Benda L, Redtenbacher L (1977) Zur Dosierung der Streptokinase beim akuten Herzinfarkt. In: Sailer S (ed) Die Fibrinolyse — Behandlung des akuten Myokardinfarktes. Hollinek, Wien, p 19.
Benninger GW, Kreps SI (1971) Aggregation phenomenon in an IgG multiple myeloma resulting in the hyperviscosity syndrome. Am J Med 51: 287.
Bergentz S, Gelin L, Rudenstam C, Zederfeldt B (1963) The viscosity of whole blood in trauma. Acta Chir Scand 126: 289.
Bergqvist G, Zetterström R (1974) Blood viscosity and peripheral circulation in newborn infants. Acta Paediatr Scand 63: 865.
Bernstein EF, Castaneda AR (1968) Studies of shear-dependent blood viscosity in extracorporal circulation. In: Copley AL (ed) Hemorheology. Pergamon, New York, p 433.
Blarney SL, McArdle BM, Burns P, Lowe GDO, Forbes CD, Carter DC, Prentice CRM (1983) Prevention of fibrinolytic shut-down after major surgery by intramuscular stanozolol. Thromb Res 31: 451.
Blendin R (1975) Untersuchungen über den Einfluß einiger vasoaktiver Pharmaka auf die Fließeigenschaften des Blutes. Dissertationsschrift, Frankfurt am Main.
Block KJ, Maki DG (1973) Hyperviscosity syndromes associated with immunoglobulin abnormalities. Hematology 10: 113.
Blume J, Kiesewetter H, Bulling BJ, Gerhards M (1984) Einfluß von Betablockern auf klinische und hämorheologische Parameter bei AVK-Patienten. In: Heilmann L, Kiesewetter H, Ernst E (eds) Klinische Rheologie und Beta-1-Blockade. Zuckschwerdt, München, p 153.
Bode WA, Fonk T, van der Veen EA, van der Meer J (1982) Effects of long-term treatment with isox-suprine on the blood viscosity profile in maturity-onset diabetics. Clin Hemorheol 2: 189.
Böhme H, Everts B (1981) Hemodilution combined with defibrinogenation. Bibl Haematol 47: 165.
Böhme H, Everts B (1985) Hämodilution und Defibrinogenierung in der Behandlung arterieller Durchblutungsstörungen. Int Welt 8: 225.
Bös W (1976) Wirkungen zweier Diuretika auf die Fließeigenschaften des Blutes bei Patienten mit chronisch venösen ödemen. Dissertationsschrift, Frankfurt am Main.
Bogar L, Matrai A, Walker RT, Flute PT, Dormandy JA (1985) Haemorheological effects of a 5-HT2receptor antagonist (ketanserin). Clin Hemorheol 5: 115.
Bogar L, Flute PT, Walker RT, Dormandy JA (1985) Haemorheological effects of a 5-HT2 receptor antagonist (ketanserin) in patients with leg ischaemia (Abstract). Clin Hemorheol 5: 739.
Boisseau MR (1985) Changes in blood filtration during acute C. V. A. Effect of treatment (Abstract). Clin Hemorheol 5: 712.
Boisseau MR, Freyburger G, Louit F, Roudaut MF, Sense JM, Manciet G, Julien J (1985) Vascular pathology and hemorheological disorders: trial of buflomedil, pentosan polysulfate and vinburnin (Abstract). Clin Hemorheol 5: 724.
Bollinger A, Simon HJ, Köhler R, Lüthy E (1968) Wirkung von niedermolekularem Dextran auf die Blutviskosität und Extremitätendurchblutung. Z Kreislaufforsch 57: 456.
Bonniot R, Quemada D, Dufaux J, Hazard B, Lamberth M (1980) Traitement des arteriopathies par l’acetylsalicylate de lysine — Resultats cliniques chez 68 malades avec 97 etudes rheologiques. Arch Méd Ouest 12: 577.
Borgolte H (1981) Veränderungen der Blutviskosität und-elastizität bei der Gabe von Dextran 40. In: Breddin K (ed) Thrombose und Atherogenese. Pathophysiologic und Therapie der arteriellen Verschlußkrankheit. Bein-Beckenvenen-Thrombose. Witzstrock, Baden-Baden, p 119.
Botas L, Freitas JP, Teresa Laginha M, Barroca JP, Martins JM, Fátima Silva M, Martins E Silva J (1983) The effects of pentoxyfilline on blood filterability and functional capacity in patients with stable angina pectoris under a beta-blocking trial (Abstract). Clin Hemorheol 3: 328.
Boyan CP, Underwood PS, Howland WS (1966) The effect of operation, anesthesia and plasma expanders on blood viscosity. Anesthesiology 27: 279.
Breddin K, Ehrly AM, Fechler L, Frick D, König H, Kraft H, Krause H, Krzywanek HJ, Kutschera J, Lösch HW, Ludwig O, Mikat B, Rausch F, Rosenthal P, Sartory S, Voigt G, Wylicil P (1973) Die Kurzzeitfibrinolyse beim akuten Myokardinfarkt. Dtsch Med Wochenschr 98: 861.
Brinkmann R, Zijlstra WG, Jansonius NJ (1963) Quantitative evaluation of the rate of rouleaux formation of erythrocytes by measuring light reflection (“Syllectometry ”). Proc Kon Ned Akad Wet (Ser C) 66: 236.
Brown MM, Pearson TC, Marshall J (1981) Effect of changes in plasma viscosity on cerebral blood flow in man (Abstract). Clin Hemorheol 1: 457.
Brown MM, Marshall J (1982) Effect of plasma exchange on blood viscosity and cerebral blood flow. Br Med J 284: 1733.
Browning GG, Gatehouse S, Lowe GDO (1986) Blood viscosity as a factor in sensorineural hearing impairment. Lancet 1: 121.
Brügger W, Imhof P, Müller P, Moser P, Reubi F (1985) Effect of nitroglycerin on blood rheology in healthy subjects. Eur J Clin Pharmacol 29: 331.
Buchan PC, MacDonald HN (1980) Altered haemorheology in oral-contraceptive users. Br Med J 280: 978.
Buchan PC (1982) Haemorheological consequences of oestrogen and progestagen therapy. Int J Microcirc Clin Exp 1: 262.
Buffet E, Adjizian JC, Pignon B, Droulle C, Potron G (1985) Rheological and haemostatic parameters in geriatric population under pentosane polysulfate treatment (Abstract). Clin Hemorheol 5: 738.
Burch GE, De Pasquale NP (1962) Hematocrit, blood viscosity and myocardial infarction. Am J Med 32: 161.
Burch GE, De Pasquale NP (1963) Phlebotomy — Use in patients with erythrocytosis and ischemic heart disease. Arch Intern Med 111: 687.
Burch GE (1965) Hematocrit, viscosity and coronary blood flow. Dis Chest 48: 225.
Burke AM, Chien S, McMurty JG (1979) Effects of low molecular weight dextran on blood viscosity after craniotomy for intracranial aneurysms. Surg Gynecol Obstet 148: 9.
Burns P, Small M, Blarney SL, Lowe GDO, Forbes CD (1983) Effects of stanozolol on viscosity in volunteers and in surgical patients (Abstract). Clin Hemorheol 3: 287.
Burton-Opitz R (1900) Vergleich der Viscosität des normalen Blutes mit der des Oxalatblutes, des defibrinirten Blutes und des Blutserums bei verschiedener Temperatur. Arch Ges Physiol 82: 464.
Burton-Opitz R (1904) The changes in the viscosity of the blood produced by alcohol. J Physiol 32: 8.
Burton-Opitz R (1906) Weitere Studien über die Viskosität des Blutes. Arch Ges Physiol 112: 189.
Burton-Opitz R (1911) The viscosity of the blood. JAMA 57: 353.
Buskard NA, Galton DA, Goldman JM, Kohner EM, Grindle CF, Newman DL, Twinn KW, Lowenthal RM (1977) Plasma exchange in the long term management of Waldenström’s macroglobulinaemia. Can Med Assoc J 117: 135.
Buskard NA (1981) Blood flow studies in the hyperviscosity syndrome before and after plasma exchange. In: Borberg H, Reuter P (eds) Plasma exchange therapy. Thieme, Stuttgart, p 89.
Cabannes R, Pistonne M, Faget P, Meite M, Bassembie J (1983) Rheological study of sickle-cells in S.C.D. patients treated with pentoxifylline — A comparative study (Abstract). Clin Hemorheol 3: 232.
Cäsar K, Wegener B, Hossmann K (1980) Wirkung von Isosorbiddinitrat auf Blutdruck, peripheren Gefäßwiderstand und venöse Kapazität bei Patienten mit arterieller Hypertonie. In: Rudolph W, Schrey A (eds) Nitrate II — Wirkung auf Herz und Kreislauf. Urban und Schwarzenberg, München, p 58.
Caimi G, Frazzetta F, Capobianco D, Catania A, Francavilla G, Sarno A (1982) Comportamento del pattern emoreologico in soggetti con ipertensione essenziale trattati con beta-bloccanti. Clin Ter 103: 383.
Caimi G, Catania A, Frazzetta F, Capobianco D, Sarno A (1983) Essential hypertension — The behaviour of the haemorheological determinants and their trends during beta-blocker treatment. Jpn Heart J 24: 723.
Caimi G, Catania A, Frazzetta F, Capobianco D, Francavilla G, Romano A, Sarno A (1983) Relievi emoreologici in un gruppo di vasculopatici aterosclerotici trattati con suloctidil. Ric Clin Lab 13(Suppl 3): 465.
Calabrò A, Rossi A, Piarulli F, Coscetti G, Baiocchi MR, Fellin R, Crepaldi G (1985) Effect of sulo-dexide administration in a group of patients with peripheral atherosclerosis (Abstract). Clin Hemorheol 5: 723.
Calabrò A, Rossi A, Baiocchi MR, Coscetti G, Fellin R, Crepaldi G (1985) Effetto del sulodexide su alcuni parametri emoreologici in un gruppo di pazienti con vasculopatia arteriosclerotica periferica. Ric Clin Lab 15(Suppl 1): 455.
Calvert GD, Blight L, Franklin J, Oliver J, Wise P, Gallus AS (1980) The effects of Clofibrate on plasma glucose, lipoproteins, fibrinogen and other biochemical and haematological variables in patients with mature onset diabetes mellitus. Eur J Clin Pharmacol 17: 355.
Canovi MC, Spandri A, Lambrughi S, Marcelli D, Piovella C (1985) Confronto in vivo ed in vitro del sangue di soggetti trattati con pentossifillina nei riguardi dell’aggregazione intravasale degli eritrociti. Ric Clin Lab 15(Suppl 1): 603.
Cappelli R, Pecchi S, Pieragalli D, Acciavatti A, Galigani C, Messa GL, Vittoria A, Guerrini M, Forconi S, Di Perri T (1985) Effect on rheological and some peripheral haemodynamic parameters of defibrotide (Abstract). Clin Hemorheol 5: 741.
Carey JS (1972) Colloids and crystalloids for volume replacement during and after surgery. In: Messmer K, Schmid-Schönbein H (eds) Hemodilution — Theoretical basis and clinical application. Karger, Basel, p 229.
Case DC jr (1982) Combination chemotherapy (M-2) protocol (BCNU, cyclophosphamide, vincristine, melphalan and prednisone) for Waldenström’s macroglobulinemia: Preliminary report. Blood 59: 934.
Catalano M, Sacchi E, Tomasini M, Coazzoli E, Parolini A, Dall’Oglio A, Libretti A (1985) La fluna-rizina nel trattamento delle arteriopatie degli arti inferiori. Ric Clin Lab 15(Suppl 1): 475.
Cavestri R, Agosti R, Clivati A, Pelucchi A, Cherubini P, Mastropasqua D, Longhini E (1985) Effects of isovolemic hemodilution on cerebral blood flow and on hemorheologic parameters in acute ischemic stroke (Abstract). Clin Hemorheol 5: 668.
Challoner T, Briggs C, Thomas DJ (1981) The effect of reducing haematocrit and viscosity on blood pressure (Abstract). Clin Hemorheol 1: 462.
Challoner T, Briggs C, Rampling MW, Thomas DJ (1986) A study of the haematological and haemorheological consequences of venesection. Br J Haematol 62: 671.
Chazan BI, Ferguson BD, Castelli WP, Touborg JNF, Balodimos MC, Rutstein DD (1969) Lipernia retinalis: Microcirculatory changes and lipid studies in family. Metabolism 18: 978.
Chevreaud C, Voisin P, Burdin D, Guimont C, Laxenaire MC, Stoltz JF (1985) Deliberate normovolemic hemodilution during the medical treatment of arteriopathy of the lower limbs: Rheological effects (Abstract). Clin Hemorheol 5: 722.
Chien S, Usami S, Taylor HM, Lundberg JL (1966) Effect of hematocrit and plasma proteins on human blood rheology at low rates of shear. J Appl Physiol 21: 81.
Chien S (1972) Present state of rheology. In: Messmer K, Schmid-Schönbein H (eds) Hemodilution — Theoretical basis and clinical application. Karger, Basel, p 1.
Chien S, Schmalzer EA, Lee MML, Impelluso T, Skalak R (1983) Role of white cells in filtration of blood cell suspensions. Biorheology 20: 11.
Chien S, Letcher RL, Pickering TG, Devereaux RB (1983) Blood rheology in hypertension (Abstract). Clin Hemorheol 3: 240.
Chmiel H (1973) Zur Blutrheologie in Medizin und Technik. Habilitationsschrift, Aachen.
Chmiel H, Pavlovic Z (1974) Der Einfluß von Carbocromen-HCl (Intensain) auf die Blutviskosität bei starken Rauchern und frischem Herzinfarkt. Z Kardiol 63(Suppl 1): 53.
Chmiel H, Pavlovic Z, Effert S (1975) Neue rheologische Methoden zur Differenzierung pathologischer Veränderungen der Blutviskosität. Verh Dtsch Ges Kreislaufforsch 41: 282.
Chmiel H, Schweizer P, Krause KH, Framing W (1976) New methods of measuring the different rheological parameters in blood (Abstract). Microcirculation 1: 94.
Chmiel H, Anadere I, Heimburg P (1981) The influence of i.v. application of pentoxifylline on the viscoelasticity of blood in patients with peripheral vascular disorders. Ric Clin Lab 11(Suppl 1): 189.
Ciuffetti G, Lupattelli G, Cusco S, Pistola L, Mercuri M, Susta A, Palazzetti D, Mannarino E (1985) Effetti del sulodexide sui parametri emoreologici, lipidici, lipoproteici ed apoproteici di pazienti iperlipemici con arteriopatia obliterante periferica. Ric Clin Lab 15(Suppl 1): 529.
Ciuffetti G, Parnetti L, Lupattelli G, Mercuri M, Orecchini G, Senin U (1985) II pattern emoreologico deterioramento mentale senile primitivo: Risultati di uno studio a lungo termine con l’impiego piracetam e pentossifillina. Ric Clin Lab 15(Suppl 1): 583.
Cline MJ, Solomon A, Berlin NI, Fahey JL (1963) Anemia in macroglobulinemia. Am J Med 34: 213.
Clinical Hemorheology 7 (1987) Nr 1 (Special issue).
Clivati A, Agosti R, Cherubini P, Ogliari L, Belloni A, Longhini E (1985) Effetti del salasso isovolumetrico sulle proprietà reologiche del sangue in corso di insufficienza respiratoria e policitemia secondaria. Ric Clin Lab 15(Suppl 1): 611.
Clivati A, Agosti R, Cherubini P, Spelta P, Bonvini G, Ricciardi G, Pagliano L (1985) Hemorheologic properties in beta-thalassemia (Abstract). Clin Hemorheol 5: 686.
Coccheri S, Palareti G, Poggi M, Tricarico MG (1982) Improvements in the rheologic properties of blood induced by medium-term treatment with buflomedil in diabetic patients. J Int Med Res 10: 394.
Coccheri S, Palareti G, Parenti M, Poggi M, Tricarico MG (1982) Buflomedil improves erythrocyte deformability in diabetic patients (Abstract). Haemostasis 12: 119.
Cokelet GR, Merrill EW, Gilliland ER, Shin H, Britten A, Wells RE (1963) The rheology of human blood. Measurements near and at zero shear rate. Trans Soc Rheol 7: 303.
Copley AL (1949) Rheological problems in biology. In: Burgers JM et al. (eds) Proceedings of the International Congress on Rheology, Holland, 1948. North-Holland, Amsterdam, 1–47; III-8.
Copley AL (1952) The rheology of blood. A survey. J Colloid sci 7: 323.
Copley AL, Stainsby G (eds) (1960) Flow properties of blood and other biological systems. Pergamon, London.
Copley AL (1962) The endoendothelian fibrin film and fibrinolysis. In: Proceedings of the 8th International Congress on Hematology, Tokyo, 1960, vol 3. Pan-Pacific, Tokyo, p 1648.
Copley AL (1968) Hemorheology. Pergamon, New York.
Copley AL, Seaman GVF (1981) The meaning of the terms rheology, biorheology and hemorheology (Editorial). Clin Hemorheol 1: 117.
Copley AL (1982) The future of the science of biorheology. Biorheology 19: 47.
Copley AL (1985) The history of clinical hemorheology. Clin Hemorheol 5: 765.
Couette M (1890) Etudes sur le frottement des liquides. Ann Chim Phys 21: 433.
Crawford J, Cox EB, Cohen HJ (1985) Evaluation of hyperviscosity in monoclonal gammopathies. Am J Med 79: 13.
Crolle G, Cucca S, Gosparini B, Baso G, Martechini A, Urbani N, Vattolo S (1985) E’possibile migliorare la deformabilità eritrocitaria nell’anziano vasculopatico? Minerva Med 76: 1349.
Crowell JW, Ford RG, Lewis VM (1959) Oxygen transport in hemorrhagic shock as a function of the hematocrit ratio. Am J Physiol 196: 1033.
Danilov IP, Makarevich AE (1985) Correction of hemorheological disorders in patients with chronic obstructive bronchitis. Klin Med (Mosk) 63(7): 49.
Davis E, Rozov H (1973) The effects of xanthinol nicotinate on the small blood vessels. Bibl Anat 11: 334.
Davis E, Rozov H (1975) Xanthinol nicotinate in peripheral vascular disease. Practitioner 215: 793.
Dawidson I, Barrett J, Miller E, Litwin MS (1975) Blood viscosity studies in postoperative patients. Bibl Haematol 41: 76.
De Clerck F, De Cree J, Brugmans J, Wellens D (1977) Reduction by flunarizine of the increase of blood viscosity after ischemic forearm occlusion. Arch Int Pharmacodyn Ther 230: 321.
De Clerck F (1985) Rheological effects of flunarizine, a Ca2+-entry blocker: rationale and mechanism (Abstract). Clin Hemorheol 5: 759.
De Cree J, De Cock W, Geukens H, De Clerck F, Beerens M, Verhaegen H (1979) The rheological effects of cinnarizine and flunarizine in normal and pathologic conditions. Angiology 30: 505.
De Cree J, Leempoels J, Geukens H, De Cock W, Verhaegen H (1981) RBC deformability in patients with essential hypertension and acute myocardial infarction. Improvement by treatment with a selective 5-HT2 antagonist (R 41468). Abstract-Booklet 2nd Europ Conf Clin Haemorheol, London, p 31.
De Cree J, Leempoels J, De Cock W, Geukens H, Verhaegen H (1983) Hemorheological effects of ketanserin, a 5-HT2 receptor antagonist. Abstract-Booklet 1st Europ Meeting Hypertension, Milan, Italy.
De Cree J, Leempoels J, Geukens H, De Cock W, Verhaegen H (1983) Oral treatment with ketanserin in intermittent claudication. Abstract-Booklet 13th World Congr Int Union Angiol, Rochester, Minnesota, USA.
Deguchi K, Ito T, Shima H, Uno N, Nakamori I, Ueno H, Umemoto D, Ito U, Kobayashi T, Li S, Tanaka T, Kato M, Konishi M, Kudo M, Kusunose K, Yamada S (1977) Pentoxifylline. Clinical use of pentoxifylline — Concerning blood viscosity and platelet function. Mie Med 21(3): 375.
Delsignore R, David S, Francia MT, Bottazzi G, Crotti G (1985) Alterazioni emoreologiche determinate dall’uremia. Effetti dell’emodialisi. Ric Clin Lab 15(Suppl 1): 335.
De Quiros JFB, Hess H (1976) Über den Einfluß von Isoxsuprin-HCl auf die Fließfähigkeit des Blutes. Fortschr Med 94: 1661.
Derksen RHWM, Hene RJ, Gmelig Meyling FHJ, Kater L (1983) Plasma exchange in the treatment of cryoglobulinemia. Neth J Med 26: 294.
Determann H (1908) Das Verhalten der Blutviskosität bei Joddarreichung. Dtsch Med Wochenschr 34: 871.
Diamantopoulos EJ, Raptis S, Karaiskos K, Hadjidakis D, Moulopoulos S (1981) Haemorheo-logical parameters in diabetics under different modes of treatment (Abstract). Clin Hemorheol 1: 465.
Diehm C, Gallasch G, Wirth A, Schettler G (1984) Hämorheologische Veränderungen nach körperlichem Training. Dtsch Z Sportmed 8: 286.
Di Lollo F, Fazzini G, Avanzi G (1983) L’emodiluizione e la plasmaferesi nella terapia delle sindromi da iperviscosità. Ric Clin Lab 13(Suppl 3): 225.
Dintenfass L (1966) A preliminary outline of the blood high viscosity syndromes. Arch Intern Med 118: 427.
Dintenfass L, Rozenberg MC (1967) Some observations on the viscosity of blood in various diseases. Effect of intravenous heparin. Angiologica 4: 116.
Dintenfass L (1968) Fluidity (internal viscosity) of the erythrocyte and its role in physiology and pathology of circulation. Haematologia 2: 19.
Dintenfass L (1971) Blood microrheology — Viscosity factors in blood flow, ischaemia and thrombosis. Butterworths, London.
Dintenfass L, Milton GW (1973) Blood viscosity factors and prognosis in malignant melanoma. Effect of ABO blood groups. Med J Aust 1: 1091.
Dintenfass L, Lake B (1976) Beta blockers and blood viscosity. Lancet 1: 1026.
Dintenfass L (1976) Rheology of blood in diagnostic and preventive medicine. An introduction to clinical haemorheology. Butterworths, London.
Dintenfass L, Seaman GVF (1981) Blood viscosity in heart disease and cancer. Pergamon, New York.
Dintenfass L (1981) Hyperviscosity in hypertension. Pergamon, New York.
Dintenfass L (1983) Action of drugs on the aggregation and deformability of red cells: effect of ABO blood groups. Ann NY Acad sci 416: 611.
Dintenfass L (1983) Effect of drugs and diet on blood viscosity, red cell aggregation and red cell rigidity (Abstract). Clin Hemorheol 3: 288.
Dintenfass L (1985) Blood viscosity. Hyperviscosity and hyperviscosaemia. MTP Press, Lancaster.
Di Perri T, Forconi S, Guerrini M, Laghi Pasini F, Del Cipolla R, Rossi C, Agnusdei D (1977) Action of cinnarizine on the hyperviscosity of blood in patients with peripheral obliterative arterial disease. Proc R Soc Med 70(Suppl 8): 25.
Di Perri T, Forconi S, Agnusdei D, Guerrini M, Laghi Pasini F (1978) The effects of intravenous isoxsuprine on blood viscosity in patients with occlusive peripheral arterial disease. Br J Clin Pharmacol 5: 255.
Di Perri T, Forconi S, Guerrini M, Laghi Pasini F, Del Cipolla R, Rossi R, Agnusdei D (1979) Action of cinnarizine on the hyperviscosity of blood in patients with peripheral obliterative disease. Angiology 30: 13.
Di Perri T, Forconi S, Guerrini M, Pecchi S, Pieragalli D, Cappelli R, Acciavatti A (1981) Influence of non-selective and selective beta adrenoceptor blockade on isoxsuprine-dependent hemodynamic and rheologic changes. Angiology 32: 257.
Di Perri T, Forconi S, Di Lollo F, Pozza G (1984) Le sindromi da iperviscosità ematica. Fisiologia, patologia e clinica. Pozzi, Roma.
Ditzel J, Bang HC, Thorsen N (1969) The effect of Dextran 40 on hemorheological factors during the course of acute myocardial infarction. Bibl Anat 10: 132.
Djurdjevic L, Bräuer H, Rahlfs V (1976) Kontrollierte klinische Prüfung von Chemotherapeutika zur Senkung der Blutfette Cholesterin und Triglyzeride sowie deren Einfluß auf die Fluidität des Blutes. Therapiewoche 26: 5556.
Dodds AJ, O’Reilly MJG, Yates CJP, Cotton LT, Flute PT, Dormandy JA (1979) Haemorheological response to plasma exchange in Raynaud’s syndrome. Br Med J 2: 1186.
Dodds AJ (1981) Plasma exchange. In: Lowe GDO, Barbenel JC, Forbes CD (eds) Clinical aspects of blood viscosity and cell deformability. Springer, New York, p 227.
Doletskii AS, Dallakian NO, Aksel’rov AM, Nazarova NB, Sokolova VA (1985) Correction of disorders of peripheral circulation with trental in children in the postoperative period. Anesteziol Reanimatol 4: 56.
Donaldson DR, Kester RC, Russell CW, Wiggins PA, Hall TJ (1981) Does oxpentifylline (Trental) have a place in the treatment of intermittent claudication? (Abstract). Clin Hemorheol 1: 469.
Donaldson DR, Hall TJ, Kester RC, Ramsden CW, Wiggins PA (1984) Does oxpentifylline (“Trental ”) have a place in the treatment of intermittent claudication? Curr Med Res Opin 9: 35.
Dorigo B, Raspanti D, Trapani M, Albanese B, Cameli AM, Digiesi V (1985) Studio flussimetrico, termometrico e reologico nelle arteriopatie obliteranti degli arti inferiori trattate con buflomedil. Minerva Med 76: 269.
Dormandy JA (1970) Clinical significance of blood viscosity. Ann R Coll Surg Engl 47: 211.
Dormandy JA (1971) Influence of blood viscosity on blood flow and the effect of low molecular weight dextran. Br Med J 4: 716.
Dormandy JA, Edelman JB (1973) High blood viscosity: An aetiological factor in venous thrombosis. Br J Surg 60: 187.
Dormandy JA, Hoare E, Khattab AH, Arrowsmith DE, Dormandy TL (1973) Prognostic significance of rheological and biochemical findings in patients with intermittent claudication. Br Med J 4: 581.
Dormandy JA, Gutteridge JMC, Hoare E, Dormandy TL (1974) Effect of Clofibrate on blood viscosity in intermittent claudication. Br Med J 4: 259.
Dormandy JA, Goyle KB, Postlethwaite J (1976) Improvement in the rate of vascular graft patency with controlled postoperative defibrinogenation (Abstract). Br J Surg 63: 661.
Dormandy JA, Goyle KB (1976) Clinical improvement in peripheral circulation by controlled defibrinogenation (Abstract). Br J Surg 63: 661.
Dormandy JA, Hoare E, Postlethwaite H (1976) Blood viscosity of patients with intermittent claudication — Concept of “Rheological Claudication ”. Biorheology 13: 161.
Dormandy J, Postlethwaite J, Goyle K (1977) Haemorheological therapy. Bibl Anat 16: 481.
Dormandy JA, Goyle KB, Reid HL (1977) Treatment of severe intermittent claudication by controlled defibrination. Lancet 1: 625.
Dormandy JA, Reid HL (1978) Controlled defibrination in the treatment of peripheral vascular disease. Angiology 29: 80.
Dormandy JA (1981) Drug modification of erythrocyte deformability. In: Lowe GDO, Barbenel JC, Forbes CD (eds) Clinical aspects of blood viscosity and cell deformability. Springer, Berlin, p 251.
Dormandy JA, Ernst E (1981) Effects of buflomedil on erythrocyte deformability. Angiology 32: 714.
Dormandy JA, Yates CJP, Berent GA (1981) Clinical relevance of blood viscosity and red cell deformability including newer therapeutic aspects. Angiology 32: 236.
Dormandy J (ed) (1983) Red cell deformability and filterability. Martinus Nijhoff, Boston.
Dormandy JA, Matrai A (1983) Assessment of pharmacological agents with a hemorheological action. Ann NY Acad sci 416: 599.
Dormandy JA (1984) Effects of anaesthesia and surgery on the flow properties of blood. Microcirculation, Endothelium and Lymphatics 1: 151.
Dormandy J, Ernst E, Matrai A (1986) Clinical aspects of white cell rheology. Clin Hemorheol 6: 455.
Dowd PM, Kovacs IB, Bland CJH, Kirby JDT (1981) Effect of prostaglandins I2 and E1 on red cell deformability in patients with Raynaud’s phenomenon and systemic sclerosis. Br Med J 283: 350.
Dowd PM, Kovacs IB, Kirby JDT, Turner P (1981) Decreased deformability of red blood cells in patients with systemic sclerosis and the effect of prostaglandins I2 and E1 on red blood cell deformability (Abstract). Clin Hemorheol 1: 469.
Droßbach M (1923) Beziehungen zwischen Blutviskosität und Blutkörperchen, ihre Beeinflussung durch Coffein. Z Gesamte Exp Med 34: 84.
Drouin P, Rousselle D, Pointel JP, Voisin G, Stoltz JF, Clemens AH, Debry G (1979) Dynamic study of the blood viscosity of insulin-dependent diabetics by means of an artificial pancreas. Horm MetabResll (Suppl 18): 107.
Drouin P, Rousselle D, Stoltz JF, Guimont C, Gaillard S, Vernhes G, Debry G (1981) Study of blood viscosity and erythrocyte parameters in diabetic patients using an artificial pancreas. Scand J Clin Lab Invest 41(Suppl 156): 165.
Drummond AR, Drummond MM, Mackenzie PJ, Lowe GDO, Smith G, Forbes CD, Wishart HY (1980) The effect of general and spinal anaesthesia on red cell deformability and blood viscosity in patients undergoing surgery for fractured neck of femur. In: Stoltz JF, Drouin P (eds) Hemorheology and diseases. Doin, Paris, p 445.
Durocher JR, Weir MS, Lundblad EG, Patow WE, Conrad ME (1975) Effect of oral contraceptives and pregnancy on erythrocyte deformability and surface charge (39037). Proc Soc Exp Biol Med 150: 368.
Easthope PL, Brooks DE (1980) A comparison of rheological constitutive functions for whole human blood. Biorheology 17: 235.
Ehringer H, Dudczak R, Kleinberger G, Lechner K, Reiterer W (1971) Arvin: Schlangengift als neue Therapiemöglichkeit bei Durchblutungsstörungen. Wien Klin Wochenschr 83: 411.
Ehringer H (1971) Effects of the purified fraction of the malayan pit viper (Arvin) alone and in combination with streptokinase in patients with arterial occlusion. Abstract-Booklet Symposium ”Problems related to fibrinolysis ”, Capo Boi, Sardinia.
Ehringer H, Dudczak R, Lechner K, Widhalm F (1972) Therapeutische Defibrinierung mit Schlangengift (Arwin) bei arteriellen Durchblutungsstörungen. Verh Dtsch Ges Inn Med 78: 624.
Ehringer H, Dudczak R, Widhalm F, Lechner K (1972) Thrombolytische Therapie bei subakuten und chronischen Gliedmaßenarterienverschlüssen. In: Sailer S (ed) Aktuelle Probleme der Fibrino-lyse-Behandlung. Hollinek, Wien, p 41.
Ehringer H, Dudczak R, Lechner K (1973) Therapeutische Defibrinierung mit Ancrod. Dtsch Med Wochenschr 98: 2298.
Ehringer H, Dudczak R, Widhalm F, Lechner K (1974) Wirkung und Möglichkeiten einer Defibrinierung in der Therapie arterieller Durchblutungsstörungen (Untersuchungen mit Arwin). In: Ehringer H (ed) Fortschritte der konservativen Therapie der peripheren arteriellen Verschlußkrankheiten (Aktuelle Probleme der Angiologie, Bd 24). Huber, Stuttgart, p 110.
Ehringer H, Dudczak R, Lechner K (1974) A new approach in the treatment of peripheral arterial occlusions: Defibrination with arvin. Angiology 25: 279.
Ehrly AM (1966) Wirkung von niedermolekularem Dextran auf Erythrozytenaggregate beim Sludge-phänomen. Med Klin 61: 982.
Ehrly AM (1967) Hämorheologische Probleme bei Venenerkrankungen. Zentralbl Phlebol 6: 338.
Ehrly AM (1969) Warum Hämorheologie? Med Trib 4;42a: 13.
Ehrly AM (1969) The effect of plasma substitutes on erythrocyte aggregation and blood viscosity. Bibl Haematol 33: 302.
Ehrly AM (1969) Untersuchungen über die Senkung der Strukturviskosität menschlichen Blutes im Hinblick auf angiologische Erkrankungen unter besonderer Berücksichtigung der Blutlipide. Habilitationsschrift, Frankfurt am Main.
Ehrly AM, Lange B (1969) Senkung der Blutviskosität und Desaggregation von Erythrocytenaggregaten durch Streptokinase. Abstract-Booklet 2nd Int Conf Int Soc Hemorheol, Heidelberg, p 22.
Ehrly AM (1970) Rheologische und mikrozirkulatorische Aspekte bei angiologischen Erkrankungen. Med Trib 5;10a: 13.
Ehrly AM (1970) Therapie mit Arwin bei peripheren Durchblutungsstörungen. Arbeitsgespräch bei Knoll AG, Ludwigshafen (siehe: Therapeutische Defibrinierung mit Ancrod. Dtsch Med Wochenschr 99 (1974), 112).
Ehrly AM (1971) Hemorheology and thrombosis. Abstract-Booklet 2nd Congr Int Soc Thromb Haemost, Oslo, Norway, p 72.
Ehrly AM (1971) Zur Wirkung von Arvin auf die Fließeigenschaften des Blutes (vorläufige Mitteilung). Herrenalber Angiologisches Gespräch.
Ehrly AM (1971) Therapie der venösen Stauung durch Verbesserung der Fließeigenschaften des Blutes. Abstract-Booklet 4th Int Congr Phlebol, Lucerne, p 92.
Ehrly AM, Fink MM (1971) Blutkörperchensenkungsgeschwindigkeit (BSG) bei verschiedenen Hämatokritwerten. Med Welt 22: 1960.
Ehrly AM (1971) Disaggregation of erythrocyte aggregates and decrease of the structural viscosity of human blood by 2-phenyl-benzyl-aminomethyl-imidazolidine (Antazolin). In: Hartert HH, Copley AL (eds) Theoretical and Clinical Hemorheology. Springer, Berlin, p 184.
Ehrly AM, Lange B (1971) Reduction in blood viscosity and disaggregation of erythrocyte aggregate by streptokinase. In: Hartert HH, Copley AL (eds) Theoretical and Clinical Hemorheology. Springer, Berlin, p 366.
Ehrly AM (1972) Rheological changes due to fibrinolytic therapy. In: Messmer K, Schmid-Schönbein H (eds) Hemodilution — Theoretical basis and clinical application. Karger, Basel, p 289.
Ehrly AM (1972) Verbesserung der Fließeigenschaften des Blutes über eine therapeutische Defibrinierung mit Arwin. Gefäßwand und Blutplasma 4: 247.
Ehrly AM (1972) Influence of arwin on the flow properties of blood (Abstract). Biorheology 9: 151.
Ehrly AM (1972) Das Verhalten der Blutviskosität bei der Therapie mit Salidiuretika. Verh Dtsch Ges Inn Med 78: 617.
Ehrly AM, Breddin K (1972) Verbesserung der Fließeigenschaften des Blutes durch Arwin. Verh Dtsch Ges Inn Med 78: 620.
Ehrly AM (1973) Influence of arwin on the flow properties of blood. Biorheology 10: 453.
Ehrly AM, Jung G (1973) Circadian rhythm of blood viscosity. Biorheology 10: 577.
Ehrly AM, Jung HJ (1973) Verbesserung der Fließeigenschaften menschlichen Blutes durch subcutane Applikation von Arwin. Verh Dtsch Ges Inn Med 79: 1397.
Ehrly AM (1973) Verbesserung der Fließeigenschaften des Blutes: Ein neues Prinzip der medikamentösen Therapie chronischer peripherer arterieller Durchblutungsstörungen. Vasa 2 (Suppl 1).
Ehrly AM (1973) Senkung der Blutviskosität durch Arwin. Herz/Kreislauf 5: 133.
Ehrly AM, Bapistella B (1973) Verbesserung der Fließeigenschaften des Blutes bei der Therapie mit Streptokinase und Arwin. In: Gottstein U (ed) Koronarinsuffizienz, periphere Durchblutungsstörungen. Huber, Bern, p 315.
Ehrly AM (1974) Increased blood flow by improvement of the flow properties of blood: A new concept of the treatment of vascular diseases. In: De Temes Cordeiro GC, Mayal RC (eds) Progress on Angiology — Proceedings of the 1972 8th International Congress of Angiology, Rio de Janeiro. I.So-ciedade Brasileira de Angiologia 3: 986.
Ehrly AM (1974) Therapeutische Aspekte bei Störungen der Mikrozirkulation bei peripheren arteriellen Verschlußkrankheiten. Vasa 3: 312.
Ehrly AM, Blendin R (1974) Untersuchungen zur Frage des Einflusses von Bencyclan auf die Fließeigenschaften des Blutes. Therapiewoche 24: 2894.
Ehrly AM, Scheinpflug W (1975) Improved deformability of crenated red cells in hyperosmolar human blood by adenosin. Bibl Anat 13: 13.
Ehrly AM (1975) The effect of pentoxifylline on the flow properties of hyperosmolar blood. IRCS Med sci 3: 456.
Ehrly AM (1975) Dosis-Wirkungs-Beziehung von subcutan appliziertem Arwin® bei Patienten mit chronischen arteriellen Durchblutungsstörungen. Vasa 4: 161.
Ehrly AM, Köhler HJ, Schroeder W, Müller R (1975) Sauerstoffdruckwerte im ischämischen Muskelgewebe von Patienten mit chronischen peripheren arteriellen Verschlußkrankheiten. Klin Wochenschr 53: 687.
Ehrly AM (1975) über die Bedeutung der Erythrozytenverformbarkeit bei angiologischen Erkrankungen. Der Praktische Arzt (österreich Monatsschr Allg Med), Kongreß ”Pentoxifyllin Colloquium ”, Wien, 1975, p9.
Ehrly AM (1975) Therapie chronischer peripherer arterieller Verschlußkrankheiten mit dem Schlangengift-Enzym Arwin. Eine übersicht. Med Welt 26: 446.
Ehrly AM (1975) Ödemausschwemmung und Thrombose. Forschung und Praxis. Med Welt 26: 1877.
Ehrly AM (1975) Veränderungen der Fließeigenschaften des Blutes und der Erythrozyten bei arteriellen Verschlußerkrankungen. Med Welt 26: 1971.
Ehrly AM (1975) Beeinflussung der Verformbarkeit der Erythrozyten durch Pentoxifyllin. Med Welt 26: 2300.
Ehrly AM, Saeger-Lorenz K (1976) Kombinierte hämodiluierende und defibrinogenierende Therapie chronischer arterieller Verschlußerkrankungen (vorläufige Mitteilung). Abstract-Band Jahrestagung Ges Mikrozirkul, Aachen.
Ehrly AM (1976) Therapy of occlusive arterial disease with Ancrod. Artery 2: 98.
Ehrly AM, Köhler HJ (1976) Modifiziertes Dosisschema für die subcutane Anwendung von Arwin bei Patienten mit chronischen arteriellen Durchblutungsstörungen. Vasa 5: 155.
Ehrly AM, Köhler HJ (1976) Altered deformability of erythrocytes from patients with chronic occlusive arterial disease. Vasa 5: 319.
Ehrly AM, Köhler HJ (1976) Impaired erythrocyte deformability in patients with chronic arterial occlusive disease. In: Seki K, Mishima Y (eds) Proceedings of the 10th International Congress on Angiology, Tokyo. seis Printing, Tokyo, p 407.
Ehrly AM, Blendin R (1976) Influence of essential phospholipids on the flow properties of the blood. In: Peeters P (ed) Phosphatidylcholine. Springer, Berlin, p 228.
Ehrly AM (1976) Improvement of the flow properties of blood: A new therapeutical approach in occlusive arterial disease. Angiology 27: 188.
Ehrly AM, Saeger-Lorenz K (1977) Kombinierte hämodiluierende und defibrinogenierende Therapie chronischer arterieller Verschlußerkrankungen. Verh Dtsch Ges Kreislaufforsch 43: 332.
Ehrly AM (1977) Hemorheological in vitro findings. Are they transferable to the in vivo situation? Microvasc Res 13: 267.
Ehrly AM, Bös W (1977) Hämorheologische Untersuchungen bei der saluretischen Therapie chronisch venöser ödeme mit dehydro sanol tri®. Phlebol Proktol 6: 124.
Ehrly AM, Schmitt HJ (1977) Verfahren und Vorrichtung zum Messen der Aggregationsgeschwindigkeit von roten Blutkörperchen im Blut. Deutsches Patent Nr 2707962.
Ehrly AM, Schroeder W, Dannhof S (1977) The effect of pentoxifylline on the oxygen pressure of ischemic muscle tissue in patients with chronic arterial occlusions. IRCS Med sci 5: 411.
Ehrly AM (1978) The effect of pentoxifylline on the flow properties of human blood. Curr Med Res Opin 5: 608.
Ehrly AM, Landgraf H, Saeger-Lorenz K, Wodniok M (1979) Fließeigenschaften des Blutes bei Behandlung der essentiellen Hypertonie mit Xipamid. Dtsch Med Wochenschr 104: 218.
Ehrly AM, Schroeder W (1979) Sauerstoffdruckmessungen im ischämischen Muskelgewebe als Kontrolle therapeutischer Maßnahmen bei chronischen peripheren Durchblutungsstörungen. In: Hild R, Spaan G (eds) Therapiekontrolle in der Angiologie. Witzstrock, Baden-Baden, p 83.
Ehrly AM, Schroeder W (1979) Zur Pathophysiologic der chronischen arteriellen Verschlußerkrankung. I. Mikrozirkulatorische Blutverteilungsstörung in der Skelettmuskulatur. Herz/Kreislauf 11: 275.
Ehrly AM (1979) The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease. J Med 10: 331.
Ehrly AM (1979) Vergleich der Fließeigenschaften des Blutes venengesunder Probanden und Patienten mit primärer Varikosis unter verschiedenen hydrostatischen Bedingungen. Phlebol Proktol 8: 169.
Ehrly AM, Köhler HJ, Schroeder W (1979) Zeitliche Beziehungen zwischen den Zunahmen des muskulären Gewebesauerstoffdruckes und der schmerzfreien Gehstrecke bei der Therapie der schweren Claudicatio intermittens mit Ancrod. Vasa 8: 28.
Ehrly AM (1979) New pathophysiological concept of ischemic diseases. Microcirculatory Maldistribution (MBM). In: Puel P, Boccolon H, Enjalbert A (eds) Hemodynamics of the limbs. Toulouse, p 429.
Ehrly AM, Landgraf H, Saeger-Lorenz K (1980) Quantification of the effects of rheologically active drugs in patients with vascular diseases. In: Stoltz JF, Drouin P (eds) Hemorheology and diseases. Doin, Paris, p 665.
Ehrly AM (1980) New pathophysiological concept of ischemic diseases. Microcirculatory Blood Maldistribution (MBM). Bibl Anat 20: 456.
Ehrly AM (1980) Mikrozirkulatorische Blutverteilungsstörung als pathophysiologisches Prinzip bei chronischen arteriellen Verschlußerkrankungen. In: Müller-Wiefel H (ed) Mikrozirkulation und Blutrheologie. Witzstrock, Baden-Baden, p 59.
Ehrly AM (1981) Therapeutische Hypofibrinogenämie. In: Vinazzer H (ed) Thrombose und Embolic (Anaesthesiologie und Intensivmedizin, Bd 134). Springer, Berlin, p 307.
Ehrly AM (1981) Welchen Stellenwert haben Gesamtblutviskosität, Erythrozytenverformbarkeit und Erythrozytenaggregation? Dtsch Med Wochenschr 106: 35.
Ehrly AM, Landgraf H (1981) Analysis of the specific hemorheological effects of low molecular weight dextran (LMWD)-and saline-infusions in healthy volunteers. Clin Hemorheol 1: 99.
Ehrly AM, Landgraf H (1981) Influence of vincamine on the flow properties of blood (Abstract). Clin Hemorheol 1: 471.
Ehrly AM (1982) Are there haemorheological reasons for using drugs acting on red cell deformability? Clin Hemorheol 2: 305.
Ehrly AM (ed) (1983) Determination of tissue oxygen pressure in patients. Pergamon, Oxford.
Ehrly AM (ed) (1983) Klinische Hämorheologie: Eine Bestandsaufnahme. Zuckschwerdt, München.
Ehrly AM (1983) Verbesserungen der nutritiven Durchblutung bei peripheren ischämischen Erkrankungen. Vasa 12 (Suppl 11).
Ehrly AM (1983) Hemorheological therapy by fibrinogen-lowering drugs (Abstract). Clin Hemorheol 3: 550.
Ehrly AM, Landgraf H (1983) Einfluß von Isosorbiddinitrat auf die Fließeigenschaften des Blutes von Patienten mit chronischer arterieller Verschlußkrankheit. Abstract-Band 2. Kongr Dtsch Ges Klin Hämorheol, München.
Ehrly AM, Landgraf H (1984) Einfluß von Isosorbiddinitrat auf die Fließeigenschaften des Blutes von Patienten mit chronischer arterieller Verschlußkrankheit. In: Ehrly AM (ed) Therapie mit hämorheologisch wirksamen Substanzen. Zuckschwerdt, München, p 145.
Ehrly AM, Landgraf H (1984) Effects on muscle tissue oxygen tension in claudicants: Infusions of 5% albumin versus 10% hydroxyethyl starch solution (200/0,5). Int J Microcirc Clin Exp 3(3-4): 521.
Ehrly AM (ed) (1984) Therapie mit hämorheologisch wirksamen Substanzen. Zuckschwerdt, München.
Ehrly AM (1984) Evaluation of enzymatic defibrinogenation. Clin Hemorheol 4: 151.
Ehrly AM (1985) Zum Stellenwert der Erythrozytenaggregation für die gestörte Mikrozirkulation. In: Kiesewetter H, Ehrly AM, Jung F (eds) Hämorheologische Meßmethoden. Münchner Wissenschaftliche Publikationen, München, p 17.
Ehrly AM (1985) Correlation between tissue oxygen supply and flow properties of blood in patients with ischemic diseases. Acta Cardiol Mediterr 3: 433.
Ehrly AM (1985) Rheoregulation: Influence of vasoconstriction and vasodilation on the flow properties of blood (Abstract). Clin Hemorheol 5: 617.
Ehrly AM (1985) Influence of urokinase on the flow properties of blood (Abstract). Clin Hemorheol 5: 728.
Ehrly AM, Landgraf H, Saeger-Lorenz K (1985) Einfluß einer Infusion von 500 ml 5%iger Humanalbumin-Lösung auf den Muskelgewebesauerstoffdruck von Patienten mit Claudicatio intermittens. In: Ehrly AM, Hauss J, Huch R (eds) Klinische Sauerstoffdruckmessung — Gewebesauerstoffdruck und transkutaner Sauerstoffdruck bei Erwachsenen. Münchner Wissenschaftliche Publikationen, München, p 96.
Ehrly AM (1986) Rheoregulation: Zeitsynchrone Veränderungen der Fließeigenschaften des Bluts in Abhängigkeit vom Sympathikotonus. In: Tillmann W, Ehrly AM (eds) Hämorheologie und Hämatologie. Münchner Wissenschaftliche Publikationen, München, p 75.
Ehrly AM (1986) Heißt bessere Durchblutung immer auch bessere Versorgung? Fortschr Med 104: 492.
Ehrly AM (1986) Diagnostic and prognostic relevance of ”extra vivum ” rheological results in vascular diseases. Clin Hemorheol 6: 211.
Ehrly AM (1986) Circadian rhythm of blood viscosity. Clin Hemorheol 6: 279.
Ehrly AM (1986) Hemorheology and tissue oxygen supply: Relationship to pharmacological treatment. Clin Hemorheol 6: 325.
Ehrly AM, Brecht HM (1987) Einfluß von Etilefrin auf verschiedene mikrozirkulatorische Parameter von Patienten mit Claudicatio intermittens. In: Strauer BE, Ehrly AM, Leschke M (eds) Fortschritte in der kardiovaskulären Hämorheologie (5. DGKH-Kongreß, Marburg, 1986). Münchner Wissenschaftliche Publikationen, München, p 71 [Abstract: Klin Wochenschr 64 (1986), 1156].
Ehrly AM, Hauss J, Huch R (eds) (1987) Clinical oxygen pressure measurement. Tissue oxygen pressure and transcutaneous oxygen pressure. Springer, Berlin.
Ehrly AM, Landgraf H, Moschner PV, Saeger-Lorenz K (1987) Hydroxyäthylstärke gegen Dextran: Verhalten des Gewebesauerstoffdruckes und der Fließeigenschaften des Blutes bei Patienten mit Claudicatio intermittens. Med Welt 38: 976.
Eisenberg S (1964) Changes in blood viscosity, hematocrit value and fibrinogen concentration in subjects with congestive heart failure. Circulation 30: 686.
Erdi A, Thomas DP, Kakkar VV, Lane DA, Dormandy JA (1976) Effects of low-dose subcutaneous heparin on whole-blood viscosity. Lancet 2: 342.
Ernst E, Dormandy J (1981) The effects of arvin and surgery on red cell filterability. Scand J Clin Lab Invest 41(Suppl 156): 317.
Ernst E (1983) Therapie-Ansatz: Fließeigenschaften des Blutes. Münch Med Wochenschr 125: 8.
Ernst E (1984) Sind ”Rheologika ” therapeutisch von Nutzen? Z Allg Med 60: 192.
Ernst E, Magyarosy I, Scherer A, Schmidlechner C (1984) Der Einfluß physikalischer Reize auf die Blutfluidität. Z Phys Med Baln Med Klim 13: 359.
Ernst E, Marshall M (1984) Verbesserung der reduzierten Erythrozytenflexibilität durch Calcium-dobesilat. Ergebnisse einer Pilotstudie. Münch Med Wochenschr 124: 125.
Ernst E, Marshall M (1984) Acetyl salicylic acid is Theologically inactive and hence an ideal reference medication for clinical trials in hemorheology. Clin Hemorheol 4: 563.
Ernst E, Matrai A (1984) Increased mortality in hypertensives treated with diuretics — A hemorheological problem? Clin Hemorheol 4: 589.
Ernst E, Rose M, Lee R (1984) Modification of transoperative changes in blood fluidity by hydroxychloroquine: A possible explanation for the drug’s antithrombotic effect. Pharmatherapeutica 4: 48.
Ernst E (1985) Mit Erfolg gegen den Hirnschlag (Editorial). Fortschr Med 103: 10.
Ernst E, Matrai A (1985) Exercise and blood fluidity (Abstract). Clin Hemorheol 5: 653.
Ernst E, Matrai A, Kollar L (1985) A randomized, double blind, placebo-controlled, crossover trial on hemodilution in claudicants — preliminary results (Abstract). Clin Hemorheol 5: 756.
Ernst E, Matrai A, Weihmayr T, Bushe B, Paulsen F (1985) Behandlung der arteriellen Verschlußkrankheit Stadium IL Hämorheologische und klinische Parameter nach oraler Applikation von Pentoxifyllin (Rentylin®). Münch Med Wochenschr 127: 917.
Ernst E, Matrai A, Weihmayr T, Paulsen F (1985) Hemorheological and clinical effects of pentoxifylline in claudicants (Abstract). Clin Hemorheol 5: 730.
Ernst E (1986) Hämorheologie für den Praktiker. Zuckschwerdt, München.
Ernst E, Matrai A, Kollar L (1986) A randomized, double-blind, placebo-controlled, crossover trial on isovolemic hemodilution in claudicants — Preliminary results. Clin Hemorheol 6: 297.
Ernst E, Matrai A, Schönhaber H, Paulsen HF, Magyarosy I (1986) Schlaganfallrehabilitation im Spiegel hämorheologischer Meßgrößen. Herz/Kreislauf 18: 30.
2nd European Conference on Clinical Hemorheology, London (1981) (Abstracts). Clin Hemorheol 1: 451.
3rd European Conference on Clinical Hemorheology, Baden-Baden (1983) (Abstracts). Clin Hemorheol 3: 221.
4th European Conference on Clinical Hemorheology, Siena (1985) (Abstracts). Clin Hemorheol 5: 611.
Everts B, Böhme H (1980) Haemostaseological and rheological changes induced by contrast media after catheter angiography. Abstract-Booklet World Congr Angiol, Athen, 1980, p 486.
Everts B, Böhme H (1981) Kontrastmittelbedingte hämostaseologische und rheologische Veränderungen nach Katheterangiographie. Münch Med Wochenschr 123: 1180.
Everts B, Böhme H (1983) Haemostaseological and rheological changes by a nonionic contrast medium after lower limb phlebography. Abstract-Booklet 13th World Congr Int Union Angiol, Rochester, Minnesota, USA.
Ewald CA (1877) Ueber die Transpiration des Blutes. Arch Anat Physiol, p 208.
Fahey JL (1963) Serum protein disorders causing clinical symptoms in malignant neoplastic disease. J Chronic Dis 16: 703.
Fahey JL, Barth WE, Solomon A (1965) Serum hyperviscosity syndrome. JAMA 192: 464.
Fahraeus R, Lindqvist T (1931) The viscosity of blood in narrow capillary tubes. Am J Physiol 96: 562.
Falchi Delitala G, Falchi Delitala N, Casali R, Crescenzi GS, Attorri L, Lombardi R, Martinangeli A, Amici S, De Santis M (1984) Studio a medio termine, in doppio cieco versus placebo, con CDP-colina nella insufficienza cerebrale senile — Aspetti psichici, endocrinologici, emoreologici e biochimico ematologici. Gazz Med Ital Arch sci Med 143: 789.
Fazzini GP, Albanese B, Manescalchi PG, Lombardi C, Pasquini G, Bartoli V (1981) Biochemical and haemorheological findings during treatment of plasma cell dyscrasias by plasmapheresis or plasma exchange (Abstract). Clin Hemorheol 1: 473.
Fazzini GP, Albanese B, Manescalchi PG, Lombardi C, Pasquini G, Bartoli V (1981) Biochemical and haemorheological findings during treatment of plasma cell dyscrasias by plasmapheresis or plasma exchange. Clin Hemorheol 1: 565.
Fendler K, Horváth L (1983) Effect of oral SP 54 treatment on the primary lipoproteinemias and on the viscosity of blood (Abstract). Clin Hemorheol 3: 293.
Ferretti PG, Gelmini G, Dall’Asta D, Butturini L, Marchini L, Passeri M (1985) L’emodiluizione normovolemica in pazienti anziani poliglobulici con insufficienza respiratoria cronica. Ric Clin Lab 15(Suppl 1): 617.
Folkow B, Mellander S (1964) Veins and venous tone. Am Heart J 68: 397.
Fontányi S, Baranyi P, Kotányi P, Sikos G (1981) Relative whole blood viscosity measurements in long term heparin treatment of atherosclerotic claudicants. Abstract-Booklet 2nd Europ Conf Clin Haemorheol, London, p 94.
Forbes CD, Barbenell J, Prentice CRM (1976) Treatment of thrombosis by sequential therapy with ancrod followed by streptokinase — Clinical pharmacology and rheology. Haemostasis 5: 348.
Forconi S (1981) Clinical pharmacology of some so-called rheological drugs. Is a rheological treatment of chronic vascular disease possible? (Abstract). Clin Hemorheol 1: 473.
Forconi S, Pieragalli D, Acciavatti A, Del Bigo C, Galigani C, Ralli L, Guerrini M, Di Perri T (1984) Positive effect of oral buflomedil on exercise-induced haemorheological damage and on claudication distance in peripheral obliterative arterial disease patients. J Int Med Res 12: 188.
Forconi S, Pieragalli D, Acciavatti A, Galigani C, Materazzi M, Ralli L, Franchi M, Laghi Pasini F, Messa GL, Bianciardi A, Rigato M, Blardi P, Guerrini M, Di Perri T (1985) Blood hyperviscosity and peripheral ischemia; the secondary hyperviscosity syndrome of ischemizing vascular diseases (Abstract). Clin Hemorheol 5: 708.
Franke I (1974) Die medikamentöse Beeinflussung der Blutviskosität unter besonderer Berücksichtigung von BL 191. Dissertationsschrift, München.
Fritz KW, Piehl W, Freyland MD (1970) Zur Frage des Zusammenhanges von renalem hyperfunktionellem Syndrom und Hyperviscosität beim Plasmocytom. Klin Wochenschr 48: 1126.
Furkalo NK, Ivashchenko TI, Romanenko AI (1985) Therapeutic efficiency of anti-anginal drugs in coronary patients in relation to their effects on blood rheological properties. Kardiologiya 25(9): 55.
Gaethgens P (1970) Die Hämodynamik der terminalen Strombahn. Untersuchungen zur Analyse des peripheren Widerstandes im Bereich des mesenterialen Gefäßbettes. Habilitationsschrift, Köln.
Gaethgens P, Kreutz F, Albrecht KH (1979) Optimal hematocrit for canine skeletal muscle during rhythmic isotonic exercise. Eur J Appl Physiol 41: 27.
Gaillard S, Schooneman F, Voisin P, Pointel JP, Rousselle D, Drouin P, Stoltz JF (1979) Effets compares sur la filtrabilité in vivo chez l’homme de deux formes galeniques de la pentoxifylline. Ann Méd Nancy 105: 1099.
Galigani C, Pieragalli D, Acciavatti A, Guerrini M, Di Perri T (1985) Activity of calcium dobesylate on plasmatic hyperviscosity of diabetic microangiopathy (Abstract). Clin Hemorheol 5: 738.
Gallasch G, Diehm C, Dörfer C, Schmitt T, Stage A, Mörl H (1985) Einfluß von körperlichem Training auf die Blutfließeigenschaften bei Claudicatio intermittens-Patienten. Klin Wochenschr 63: 554.
Gallasch G, Dörfer C, Schmitt T, Stage A (1985) Wirksamkeit von Troxerutin auf die Fließeigenschaften des Blutes unter definierten Strömungsbedingungen. Eine Doppelblindstudie an Patienten mit Retinopathia diabetica und Retinopathia arteriosclerotica. Klin Monatsbl Augenheilkd 187: 30.
Gallus AS, Gleadow F, Dupont P, Walsh J, Morley AA, Wenzel A, Alderman M, Chivers D (1985) Intermittent claudication: A double-blind crossover trial of pentoxifylline. Aust NZ J Med 15: 402.
Gelin LE (1961) Disturbance of the flow properties of blood and its counteraction in surgery. Acta Chir Scand 122: 287.
Gelin LE, Ingelman B (1961) Rheomacrodex — a new dextran solution for rheological treatment of impaired capillary flow. Acta Chir Scand 122: 294.
Gelin LE, Thorén OKA (1961) Influence of low viscous dextran on peripheral circulation in man. A Plethysmographic study. Acta Chir Scand 122: 303.
Gelin LE (1962) Flüssigkeitsersatz im Schock. In: Bock KD (ed) Schock — Pathogenese und Therapie. Springer, Berlin, p 372.
Gelin LE (1962) Rheologic disturbances and the use of low viscosity dextran in surgery. Rev Surg 19: 385.
Gelin LE (1965) Rheologie disturbances following tissue injury. In: Copley AL (ed) Symposium on Biorheology. Part 4 of the Proceedings of the Fourth International Congress on Rheology, Brown University, Providence, Rhode Island, 1963. Interscience, New York, p 299.
Gelin LE, Kerstell J, Svanborg A (1967) The effect of dietary fat on whole-blood and plasma viscosity in normal and hypercholesterolemic subjects. Acta Med Scand 181: 41.
Gelin LE (1969) Rheological aspects on shock and the experimental and clinical use of dextrans. In: Ingelman B, Grönwall A, Gelin LE, Eliasson R (eds) Properties and application of dextrans. Alm-qvist & Wiksell, Stockholm, p 43.
Gelin LE (1971) Rheological effects of dextran. In: Derrick JR, Guest M (eds) Dextrans — Current concepts of basic actions and clinical application. CC Thomas, Springfield/Illinois (USA), p 137.
Gibbs NM, Oh TE, Chester A (1984) Blood viscosity and blood film morphology during prolonged sedation with althesin. Br J Anaesth 56: 1179.
Girolami A, Cella G (1976) Effect of low-dose subcutaneous heparin on whole-blood viscosity. Lancet 2: 909.
Girolami A, Patrassi G, Bova G (1978) No change of whole blood or plasma viscosity in cardiac patients after subcutaneous calcium heparin. Folia Haematol 105: 391.
Glöckner WM, Malotta H, Sieberth HG (1983) Cascade filtration without any substitution as long-term treatment of Waldenström’s macroglobulinemia with hyperviscosity syndrome (Abstract). Clin Hemorheol 3: 337.
Glöckner WM, Sieberth HG, Schmid-Schönbein H (1985) Cascade filtration for the control of hyperviscosity by the removal of IgM-paraprotein in Waldenstrom’s macroglobulinaemia. Clin Hemorheol 5: 71.
Gluskowski J, Jedrzejewska-Makowska M, Hawrylkiewicz I, Vertun B, Zielinski J (1983) Effects of prolonged oxygen therapy on pulmonary hypertension and blood viscosity in patients with advanced cor pulmonale. Respiration 44: 177.
Goldberg K, Wirth FH, Hathaway WE, Guggenheim MA, Murphy JR, Braithwaite WR, Lubchenco LO (1982) Neonatal hyperviscosity. II. Effect of partial plasma exchange transfusion. Pediatrics 69: 419.
González de Zárate Apiñaniz J, García Domínguez R, Rodríguez Abela J, Baeza Gil C, Girón Mon-táñez R (1985) Efectos reológicos de la propanidida-cremophor EL. Rev Española Anest Rean 32: 264.
Gormsen G (1954) Does rapid dehydration in cardiac decompensation produce thrombembolic complications? Acta Med Scand 148: 61.
Gottschalk M (1985) Infusionsbedingte Blutviskositätsänderungen im Kindesalter. Kinderarztl Prax 53: 579.
Gottstein U, Held K (1969) Effekt der Hämodilution nach intravenöser Infusion von niedermolekularen Dextranen auf die Hirnzirkulation des Menschen. Dtsch Med Wochenschr 94: 522.
Gottstein U, Sedlmeyer I, Schöttler M, Gülk V (1970) Der Effekt von niedermolekularem Dextran auf die Unterschenkeldurchblutung von Gesunden und Kranken mit peripheren arteriellen Zirkulationsstörungen. Dtsch Med Wochenschr 95: 1955.
Gottstein U (1972) Allgemeine Behandlungsrichtlinien einer medikamentösen Therapie der Hirn-arterienverschlußfolgen. Verh Dtsch Ges Inn Med 78: 466.
Gottstein U (1984) Evaluation of isovolemic hemodilution. Clin Hemorheol 4: 133.
Gousios A, Shearn MA (1959) Effect of intravenous heparin on human blood viscosity. Circulation 10: 1063.
Gramstad L, Stovner J (1979) Plasma viscosity and cremophor-containing anaesthetics. Br J Anaesth 51: 1175.
Grasselli S, Parise P, Berrettini M, De Cunto M, Nenci GG (1985) Red blood cell (RBC) deformabil-ity during prostacyclin therapy (Abstract). Clin Hemorheol 5: 750.
Grindle CFJ, Buskard NA, Newman DL (1976) Hyperviscosity retinopathy — A scientific approach to therapy. Trans Ophthalmol Soc UK 96: 216.
Gross GP, Hathaway WE, McGaughey HR (1973) Hyperviscosity in the neonate. J Pediatr 82: 1004.
Groth CG, Thorsén HGR (1965) Effect of Rheomacrodex® on factors of importance for the flow properties of blood. Bibl Anat 7: 267.
Groth CG, Thorsén G (1965) The effect of Rheomacrodex and Macrodex on factors governing the flow properties of the human blood. Acta Chir Scand 130: 507.
Groth CG (1966) The effect of infused albumin and Rheomacrodex on factors governing the flow properties of the human blood. Acta Chir Scand 131: 290.
Groth CG (1968) Plasmaexpanders and the flow properties of blood. In: Copley AL (ed) Hemorheology. Pergamon, New York, p445.
Groth CG (1969) Hemorheology, plasma expanders and nutritional blood flow. Int Anesthesiol Clin 7: 239.
Gueguen M, Durand F, Grosbois B, Godinot B, Leblay R, Genetet B (1983) Haemorheology applies in the diagnosis of monoclonal dysglobulinemia and in the following-up of their plasma exchange therapy (Abstract). Clin Hemorheol 3: 335.
Gueguen M, Le Pogamp P, Avril Y, Le Goff MC, Durand F, Joyeux V, Genetet B, Chevet D (1985) Effects of haemodialysis on the rheological parameters: preliminary results (Abstract). Clin Hemorheol 5: 675.
Gülzow K, Euler HH, Löffler H (1984) Therapeutische Apheresen bei Hyperviskositätssyndromen: Klinischer Einsatz einer einfachen Methode der Viskosimetrie. In: Ehrly AM (ed) Therapie mit hämorheologisch wirksamen Substanzen. Zuckschwerdt, München, p 121.
Guerrini M, Pieragalli D, Messa GL (1981) Changes in blood viscosity after acute administration of l-eburnamonine. Drugs Exp Clin Res 7: 103.
Guerrini M, Pecchi S, Rossi C, Cappelli R, Pieragalli D, Acciavatti A (1981) Azione della pentossifil-lina sull’iperviscosità ematica e sulla emodinamica periferica in pazienti affetti da arteriopatia obliterante periferica. Ric Clin Lab 11(Suppl 1): 265.
Guerrini M, Acciavatti A, Pecchi S, Cappelli R, Sacchetti S, Forconi S, Di Perri T (1981) Effects of a single i.v. dose of nicergoline on hemorheological and hemodynamic parameters in peripheral vascular disease. A double-blind crossover study. Abstract-Booklet 2nd Europ Conf Clin Haemorheol, London, p 114.
Guerrini M, Pecchi S, Rossi C, Cappelli R, Pieragalli D, Forconi S, Di Perri T (1981) Possibility of treating vascular diseases from a rheological point of view. Study of the effects of isoxsuprine (Abstract). Clin Hemorheol 1: 475.
Guerrini M, Rossi C, Acciavatti A, Pieragalli D, Pecchi S, Cappelli R, Forconi S, Di Perri T (1981) Possibility of treating vascular diseases from a rheological point of view. Study of the effects of flunarizine and cinnarizine (Abstract). Clin Hemorheol 1: 476.
Guerrini M, Rossi C, Acciavatti A, Pieragalli D, Pecchi S, Cappelli R, Forconi S, Di Perri T (1981) Possibility of treating vascular diseases from a rheological point of view. Study of the effects of pentoxifilline (Abstract). Clin Hemorheol 1: 476.
Guerrini M, Acciavatti A, Materazzi M, Rossi C, Del Bigo C, Forconi S, Di Perri T (1982) Protective effects of buflomedil against exercise-induced reductions in regional erythrocyte deformability of patients with peripheral arterial disease. J Int Med Res 10: 387.
Guerrini M, Pieragalli D, Acciavatti A, Cappelli R, Pecchi S, Forconi S, Di Perri T (1983) L’emodi-luizione normovolemica può realmente modificare il flusso ematico degli arti? Ric Clin Lab 13(Suppl 3): 439.
Gustafsson L, Appelgren L, Myrvold HE (1985) Effects of hemodilution on skeletal muscle blood flow and blood viscosity in vivo after splanchnic stasis. Eur Surg Res 17: 366.
Haass A, Kroemer H, Brenner M, Jäger H, Weiss H, Oest A (1986) Hämorheologische und hämodynamische Effekte von Dextran 40-und HAES-200-Langzeitinfusionen. In: Tillmann W, Ehrly AM (eds) Hämorheologie und Hämatologie. Münchner Wissenschaftliche Publikationen, München, p 130.
Hagen G (1839) über die Bewegung des Wassers in engen zylindrischen Röhren. Poggendorff’s Annalen der Physik und Chemie 46: 423.
Hagenbach E (1860) über die Bestimmung der Zähigkeit einer Flüssigkeit durch Ausfluß aus Röhren. Poggendorff’s Annalen der Physik und Chemie 109: 385.
Hall JA, Barnard RJ, Pritikin N (1983) Effects of a high-complex-carbohydrate, low-fat, low-salt diet and daily exercise on blood viscosity and blood pressure in hypertensive patients (Abstract). Medicine Science Sports Exercise Madison 15: 91.
Hamazaki T, Hasunuma K, Kobayashi S, Shishido H, Yano S (1985) The effects on lipids, blood viscosity and platelet aggregation of combined use of niceritol (Perycit®) and a low dose of acetylsalicylic acid. Atherosclerosis 55: 107.
Hansen LL, Wiek J, Arntz HR (1985) Effect of isovolemic hemodilution on visual outcome of patients with ischemic and non-ischemic retinal vein occlusion (Abstract). Clin Hemorheol 5: 691.
Harke H, Pieper C, Meredig J, Rahman S, Rüssler P (1980) Rheologische und gerinnungsphysiologische Untersuchungen nach Infusion von HäS 200/0,5 und Dextran 40. Anaesthesist 29: 71.
Harkness J, Whittington RB (1971) The viscosity of human blood plasma: Its change in disease and on the exhibition of drugs. Rheol Acta 10: 55.
Haro A (1873) Essai sur la transpirabilité du sang. Gazette Hebdomadaire 11.
Hartert HH, Copley AL (eds) (1971) Theoretical and Clinical Hemorheology. Springer, Berlin.
Heidrich H, Ott M (1974) Vasodilatantien und Blutviskosität. Herz/Kreislauf 6: 542.
Heidrich H, Ott M, Schlichting K (1974) Blutviskosität unter Fludilat. In-vivo-und In-vitro-Untersuchungen. Therapiewoche 24: 2900.
Heidrich H, Schlichting K, Ott M (1975) Untersuchungen zum Einfluß von Pentoxifyllin auf die Blutviskosität und die Erythrozytenoberfläche. Med Welt 26: 1977.
Heidrich H (1975) Klinisch-experimentelle Untersuchungen zu neuen Wirkungsmechanismen sogenannter Vasodilatantien und gefäßaktiver Pharmaka. Habilitationsschrift, Berlin.
Heidrich H, Schlichting K, Ott M (1976) Changes in blood viscosity due to pentoxifylline. IRCS Med sci 4: 368.
Heidrich H, Wachta T (1977) Verhalten der Blutviskosität unter 2-, 4-und 6stündiger intravenöser Rheomakrodex-und Kochsalz-Infusion. Verh Dtsch Ges Kreislaufforsch 43: 433.
Heidrich H, Wachta T (1978) Blutviskosität unter intravenöser Langzeitinfusion von niedermolekularem Dextran (Rheomacrodex 10%). Dtsch Med Wochenschr 103: 298.
Heilmann E, Zimmermann B, Gruss P (1982) Effect of pentoxifylline on hypercoagulability in patients with polycythemia vera. IRCS Med sci 10: 594.
Heilmann E, Laage HM, Zimmermann E, Dorst KG (1982) Medikamentöse Beeinflussung der Erythrozytenflexibilität bei Sichelzellanämie. Innere Med 9: 277.
Heilmann E (1984) Hämatologische und rheologische Untersuchungen bei Polycythaemia vera. In: Ehrly AM (ed) Therapie mit hämorheologisch wirksamen Substanzen. Zuckschwerdt, München, p 186.
Heilmann L (1980) Hämorheologische Veränderungen bei Risikoschwangerschaften unter der Therapie mit Flunarizin. Vasa 9: 338.
Heilmann L, Tauber PF, Siekmann U, Ludwig H (1981) Die Fließfähigkeit des Blutes unter Einnahme von Ovulationshemmern. Zentralbl Gynakol 103: 678.
Heilmann L (1983) Hypervolemic hemodilution in the treatment of preeclampsia (Abstract). Clin Hemorheol 3: 550.
Heilmann L, Siekmann U (1983) Hämorheologische Veränderungen unter Beta-Blocker-Therapie. In: Irmer M, Weidinger H (eds) Neuere Aspekte zu: Betablockade und Tokolyse. Beltz, Weinheim, p91.
Heilmann L, Siekmann U (1983) Die hypervolämische Hämodilution bei der Präeklampsie. Infusionsther Klin Ernahr 10: 311.
Heilmann L, Siekmann U (1983) Effect of betamimeticum hexoprenaline on the erythrocyte deform-ability and sodium/potassium-cotransport system of pregnant women (Abstract). Clin Hemorheol 3: 293.
Heilmann L (1984) Hämorheologisch orientierte Therapieprinzipien in der Geburtshilfe. In: Ehrly AM (ed) Therapie mit hämorheologisch wirksamen Substanzen. Zuckschwerdt, München, p88.
Heilmann L, Kiesewetter H, Ernst E (eds) (1984) Klinische Rheologie und Beta-1-Blockade. Zuckschwerdt, München.
Heilmann L, Hirche H (1986) Rheologische Veränderungen unter Naftidrofuryl bei der Gestose. Angio 8: 33.
Heilmann L, Beez M (eds) (1987) Neuere klinische Aspekte zur Hämodilution. Schattauer, Stuttgart.
Heinen A, Brunner R, Wawer T, Roll K, Konen W, Hossmann V (1983) Randomized double-blind trial of isovolaemic haemodilution (IHD) in retinal vessel occlusion (Abstract). Clin Hemorheol 3: 233.
Hess H (1970) Neue überlegungen zur Physiopathologie obliterierender Angiopathien. 1. Zur Regulation der Durchblutung. Fortschr Med 88: 833.
Hess H (1970) Neue überlegungen zur Physiopathologie obliterierender Angiopathien. 2. Zur Pathogenese und Therapie. Fortschr Med 88: 923.
Hess H, Franke J, Jauch M (1973) Medikamentöse Verbesserung der Fließeigenschaften des Blutes. Ein wirksames Prinzip zur Behandlung von arteriellen Durchblutungsstörungen. Fortschr Med 91: 743.
Hess H, Wagner G (1974) Untersuchungen über den Einfluß von Fludilat auf die Blutviskosität. Therapiewoche 24: 2898.
Hess W (1907) Die Bestimmung der Viskosität des Blutes. Münch Med Wochenschr 45: 2225.
Hess WR (1912) Der Strömungswiderstand des Blutes gegenüber kleinen Druckweiten. Arch Anat Physiol, Physiolog Abt, Leipzig, p 197.
Hildebrandt HG (1980) Einfluß von Buflomedil auf die Fließeigenschaften des Blutes und die Gewebesauerstoffdruckwerte in der Muskulatur bei Patienten mit Claudicatio intermittens. Dissertationsschrift, Frankfurt am Main.
Hirsch C, Beck C (1901) Studien zur Lehre von der Viscosität (inneren Reibung) des lebenden, menschlichen Blutes. Dtsch Arch Klin Med 69: 503.
Hoffmann LS, Ritzmann SE (1965) Plasmapheresis — Application of modified technic in patients with monoclonal gammopathies. Tex Rep Biol Med 23: 651.
Holti G (1979) An experimentally controlled evaluation of the effect of inositol nicotinate upon the digital blood flow in patients with Raynaud’s phenomenon. J Int Med Res 7: 473.
Hossmann V, Bewermeyer H, Heiss WD (1981) A controlled trial of ancrod in the treatment of acute ischaemic stroke. Abstract-Booklet 2nd Europ Conf Clin Haemorheol, London, p41.
Hossmann V, Wegener H, Wegener B, Saborowski F, Cäsar K (1982) Hämorheologische und hämo-dynamische Wirkungen von Isosorbiddinitrat bei essentieller Hypertonie und arterieller Verschlußkrankheit. In: Engel HJ, Schrey A, Lichtlen PR (eds) Nitrate III — Kardiovaskuläre Wirkungen. Springer, Berlin, p287.
Hossmann V, Auel H (1983) Haemorheologische Therapie der arteriellen Verschlußkrankheit: Eine kontrollierte, prospektive Studie mit isovolämischer Haemodilution, Arwin und einer Kombination beider Methoden. In: Nobbe F, Rudofsky G (eds) Probleme der Vor-und Nachsorge und der Narkoseführung bei invasiver angiologischer Diagnostik und Therapie. Begutachtung arterieller und venöser Gefäßschäden. Pflaum, München, p 325.
Hossmann V, Heiss WD, Bewermeyer H, Wiedemann G (1983) Controlled trial of ancrod in ischemic stroke. Arch Neurol 40: 803.
Hossmann V (1983) Controlled study of the hemorheological effects of ancrod, isovolemic hemodilution and combined treatment in advanced stages of peripheral arterial diseases (Abstract). Clin Hemorheol 3: 309.
Hudomel J, Németh B, Palfalvy M, Farkas A (1977) Effect of calcium dobesilate (Doxium) on blood hyperviscosity in cases of diabetic retinopathy. Ophthalmic Res 9: 25.
Hudomel J, Németh B, Palfalvy M, Farkas A (1979) Wirkung von Kalzium-Dobesilat auf die Hyperviskosität des Blutes. Fortschr Med 97: 422.
Hürthle K (1900) Ueber eine Methode zur Bestimmung der Viscosität des lebenden Blutes und ihre Ergebnisse. Arch Ges Physiol 82: 415.
Humphrey PRD, Michael J, Pearson TC (1980) Management of relative polycythaemia: Studies of cerebral blood flow and viscosity. Br J Haematol 46: 427.
Humphrey PRD, Michael J, Pearson TC (1980) Red cell mass, plasma volume and blood volume before and after venesection in relative polycythaemia. Br J Haematol 46: 435.
Humphrey PRD, Du Boulay GH, Marshall J, Pearson TC, Ross Russell RW, Symon L, WetherleyMein G, Zilkha E (1981) Venesection in relative polycythaemia: Measurement of cerebral blood flow, viscosity and blood volume. Abstract-Booklet 2nd Europ Conf Clin Haemorheol, London, p 38.
Humphrey PRD, Du Boulay GH, Marshall J, Pearson TC, Ross Russell RW, Symon L, WetherleyMein G, Zilkha E (1981) Management of relative polycythaemia: Comparative effects of venesection, dextran and fludrocortisone. Abstract-Booklet 2nd Europ Conf Clin Haemorheol, London, p 112.
Humphreys WV, Walker A, Cave FD, Charlesworth D (1976) The effect of an infusion of low molecular weight dextran on peripheral resistance in patients with arteriosclerosis. Br J Surg 63: 691.
Humphreys WV, Walker A, Charlesworth D (1977) A report on the use of arvin in patients with pregangrene of the lower limb. Br J Surg 64: 31.
5th International Congress of Biorheology, Baden-Baden (1983) (Abstracts). Biorheology 20: 361.
International Symposium on filterability and red blood cell deformability, Göteborg, Sweden (1980). Scand J Clin Lab Invest 41 (Suppl 156).
Itoh C, Ishii A, Iwafune Y, Yoshimoto H (1982) Fibrinolytic therapy and blood viscosity in simple diabetic retinopathy. Nippon Ganka Kiyo 33: 2469.
Iwamoto H, Nakagowa S, Matsui N, Yoshiyama N, Shinoda T, Shibamoto T, Takenchi J (1980) An experience of plasma exchange by membrane separator for IgA myeloma. In: Sieberth HG (ed) Plasma exchange. Schattauer, Stuttgart, p377.
Jacobs MJ, Lemmens HAJ, Slaaf DW, Reneman RS (1983) The effect of ketanserin on microcirculation in patients with ischaemic handsyndromes. Abstract-Booklet 13th World Congr Int Union Angiol, Rochester, Minnesota, USA.
Jahnsen T, Skovborg F, Hansen F, Larsen J, Nordin H, Storm T (1983) Variations in blood viscosity in patients with acute cardiogenic pulmonary oedema treated with frusemide. Scand J Clin Lab Invest 43: 297.
Jahnsen T, Skovborg F, Jahnsen F, Storm TL (1985) Blood viscosity in patients receiving continuous treatment with bendroflumethiazide (Centyl® with potassium chloride). Ugeskr Laeger 147: 409.
James DR, Holland BM, Hughes MR, Jones JG, Wardrop CAJ (1984) Oxpentifylline: Effects on red cell deformability and oxygen availability from the blood in intermittent claudication. Clin Hemorheol 4: 525.
Jan K, Usami S, Smith JA (1982) Effects of transfusion on rheological properties of blood in sickle cell anemia. Transfusion 22: 17.
Jauch M (1973) Der Einfluß von verschiedenen Medikamenten auf die Viskosität des Blutes. Dissertationsschrift, München.
Johnsson R (1979) Effect of pentoxifylline on red cell flexibility and cation transport in healthy subjects and patients with hereditary spherocytosis. Scand J Haematol 23: 81.
Johnsson R, Harjola PT, Siltanen P (1981) Effect of pentoxifylline on red cell flexibility in arteriosclerotic patients and in patients with heart valve prosthesis. Scand J Clin Lab Invest 41(Suppl 156): 297.
Juhan I, Buonocore M, Calas-Aillaud MF, Moulin JP, Verdot JJ, Vague P (1980) Effects of insulin on erythrocyte deformability and platelet aggregation in diabetics on an artificial pancreas. Abstract-Booklet Int Symp filterability and red cell deformability, Göteborg, Sweden, p 53.
Juhan I, Vague P, Buonocore M, Moulin JP, Calas MF, Vialettes B, Verdot JJ (1981) Effects of insulin on erythrocyte deformability in diabetics — relationship between erythrocyte deformability and platelet aggregation. Scand J Clin Lab Invest 41(Suppl 156): 159.
Juhan I, Vague P, Buonocore M, Muratore R (1981) Deformabilite des hematies chez les diabétiques. Effets de l’insuline. Relations avec l’agrégation plaquettaire. Sem Hop Paris 57: 466.
Juhan I, Vague P, Buonocore M, Moulin JP, Jouve R, Vialettes B (1982) Abnormalities of erythrocyte deformability and platelet aggregation in insulin-dependent diabetics corrected by insulin in vivo and in vitro. Lancet 1: 535.
Jung F, Waldhausen P, Schwab J, Braun B, Molter A, Scheffler P, Kiesewetter H, Wenzel E (1986) Wirkung von Naftidrofuryl auf Mikrozirkulation und Hämorheologie bei peripherer arterieller Verschlußkrankheit im Stadium IIb. In: Tillmann W, Ehrly AM (eds) Hämorheologie und Hämatologie. Münchner Wissenschaftliche Publikationen, München, p 163.
Jung F, Waldhausen P, Schwab J, Molter A, Scheffler P, Kiesewetter H, Wenzel E (1986) Einfluß von Naftidrofuryl auf die Mikrozirkulation bei der peripheren arteriellen Verschlußkrankheit. Med Welt 37: 132.
Kallio V, Salmivalli M, Brummer P (1967) Blood viscosity changes in patients hospitalized because of acute chest pain. Cardiologia 50: 323.
Karasawa T, Hayano Y, Imai N (1982) Significance and treatment of abnormal blood viscosities in pre-eclamptic patients. Acta Obstet Gynecol Jpn 34: 599.
Keller F, Leonhardt H (1979) Amelioration of blood viscosity in sickle cell anemia by pentoxifylline — A case report. J Med 10: 429.
Keller F, Leonhardt H (1980) Verbesserung der Blutviskosität bei Sichelzellanämie durch Pentoxifyllin. Dtsch Med Wochenschr 105: 898.
Kennedy MS, Domen RE (1983) Therapeutic apheresis. Applications and future directions. Vox Sang 45: 261.
Keppeler D (1977) Untersuchungen über den Einfluß von Hydroxyäthylstärke auf die Fließeigenschaften des Blutes. Dissertationsschrift, Frankfurt am Main.
Kharkharov MA, Tirulov MT (1986) Changes in blood viscosity and central hemodynamics in patients with essential hypertension during treatment with sulfide baths. Vopr Kurortol Fizioter Lech Fiz Kult 1: 13.
Kiesewetter H, Dauer U, Gerhards M, Gesch M, Schmid-Schönbein H (1981) The single erythrocyte rigidometer (SER) as a reference for RBC-deformability tests. Biorheology 18: 157.
Kiesewetter H, Radtke H, Schneider R, Mußler K, Scheffler A, Schmid-Schönbein H (1982) Das Mini-Erythrozytenaggregometer: Ein neues Gerät zur schnellen Quantifizierung des Ausmaßes der Erythrozytenaggregation. Biomed Techn 27: 209.
Kiesewetter H, Blume J, Bulling B, Gerhards M, Jung F, Radtke H, Franke RP (1984) Mittelmolekulare Hydroxyäthylstärke als Volumenersatzmittel. Rheologische Wirkung bei peripherer arterieller Verschlußkrankheit. Dtsch Med Wochenschr 109: 1844.
Kiesewetter H, Blume J, Jung F, Radtke H, Bulling B, Gerhards M, Prünte C, Reim M (1984) Hämorheologische Aspekte peripherer arterieller Verschlußkrankheiten. Wirksamkeitsuntersuchung von Naftidrofuryl. Med Welt 35: 896.
Kiesewetter H, Blume J, Radtke H, Gerhards M, Bulling B (1984) Zur Wirksamkeit des Diuretikums Slimin® zur Unterstützung der physikalischen Entstauungstherapie beim venösen ödem. Therapiewoche 34: 4469.
Kiesewetter H, Jung F, Körber N, Blume J, Radtke H, Reim M (1984) Stellenwert hämorheologischer Parameter bei der diabetischen Retinopathie. In: Ehrly AM (ed) Therapie mit hämorheologisch wirksamen Substanzen. Zuckschwerdt, München, p 158.
Kiesewetter H, Jung F, Doenecke P, Hellstern P, Scheffler P, von Blohn G, Waldhausen P, Schwab J, Kiehl R, Wenzel E (1985) Klinische Wirksamkeit der Urokinase durch Fibrinolyse und rheologisch wirkende Fibrinogenolyse. In: Wenzel E, Hellstern P (eds) Abstracts and Handout-Poster. 29. Jahrestagung der DAB/GTH, Saarbrücken, p 131.
Kiesewetter H, Le Cotonnec JY, Gulati O (1985) Effect of bencianol on blood rheology (Abstract). Clin Hemorheol 5: 741.
Kiesewetter H, Blume J, Jung F, Bulling B, Gerhards M (1986) Rheologische Wirkung von Metoprolol bei Patienten mit essentieller Hypertonie. Klinikarzt 15: 93.
Kiesewetter H, Jung F (1986) Rheologische Therapie der peripheren arteriellen Verschlußkrankheit im Stadium IIb. Angio 8: 21.
Kiesewetter H, Jung F, Blume J, Bulling B, Franke RP (1986) Vergleichende Untersuchung von niedermolekularem Dextran-oder Hydroxyäthylstärkelösungen als Volumenersatzmittel bei Hämodilutionstherapie. Klin Wochenschr 64: 29.
Kiesewetter H, Schneider R, Jung F (1986) Einsatz von Naftidrofuryl bei Patienten mit Basilarisinsuffizienz. Med Welt 37: 211.
Kiesewetter H, Schneider R, Jung F, Blume J, Gerhards M (1986) Therapie zerebraler Mikroangiopathien. Untersuchungen mit niedermolekularer Hydroxyäthylstärke mit und ohne Pentoxifyllin. Therapiewoche 36: 50.
Kiesewetter H, Jung F, Roggenkamp HG, Nüttgens HP, Leipnitz G, Ringelstein EB, Wenzel E, Grillmaier R (1987) Zur diagnostischen Bedeutung rheologischer Parameter in der Klinik. In: Strauer BE, Ehrly AM, Leschke M (eds) Fortschritte in der kardiovaskulären Hämorheologie (5. DGKH-Kongreß, Marburg, 1986). Münchner Wissenschaftliche Publikationen, München, p 185.
Kilpatrick D, Fleming J, Clyne C, Thompson GR (1979) Reduction of blood viscosity following plasma exchange. Atherosclerosis 32: 301.
Kindl-Mascher J (1984) Untersuchungen über das Verhalten der Fließeigenschaften des venösen Blutes und des Gewebesauerstoffdruckes in der Unterschenkelmuskulatur von Patienten mit Claudicatio intermittens während einer Therapie mit Batroxobin (Defibrase). Dissertationsschrift, Frankfurt am Main.
Kirigaya H, Itoh H, Miyahara Y, Inada M, Korenaga M, Kanayama M, Niwa A, Taniguchi K (1982) The effects of drugs on blood viscosity (Abstract). Clin Hemorheol 2: 397.
Klein M, Szobor A, Bräuer H (1979) Kontrollierte Prüfung von Vincamin. Unter besonderer Berücksichtigung der Fließeigenschaften des Blutes. Med Klin 74(Sondernummer): 29.
Klemm J (1976) The treatment of arterial and venous circulatory disturbances with EPL. In: Peeters P (ed) Phosphatidylcholine. Springer, Berlin, p 237.
Klemm J, Enghofer E (1982) Strömungsgeschwindigkeit von Blut in varikösen Venen der unteren Extremitäten. Einfluß eines Venentherapeutikums (Venostasin®). Münch Med Wochenschr 124: 579.
Klemm J, Enghofer E (1983) Influence of Venostasin® on blood flow in varicose veins of the lower limbs (Abstract). Clin Hemorheol 3, Nr 150C.
Klövekorn WP, Pichlmaier H, Ott E, Bauer H, Sunder-Plassmann L, Jesch F, Messmer K (1975) Acute preoperative hemodilution in surgical patients. In: Messmer K, Schmid-Schönbein H (eds) Intentional hemodilution. Karger, Basel, p 248.
Klose HJ, Volger E, Brechteisbauer H, Heinrich L, Schmid-Schönbein H (1972) Microrheology and light transmission of blood. I. The photometric quantification of red cell aggregation and red cell orientation. Pflüger’s Arch 333: 126.
Knarr W (1975) Beeinflussung der Fließeigenschaften des Blutes durch Pentoxifyllin. Dissertationsschrift, Frankfurt am Main.
Kobayashi S, Hamazaki T, Hirai A, Terano T, Tamura Y, Kanakubo Y, Yoshida S, Fujita T, Kumagai A (1985) Epidemiological and clinical studies of the effect of eicosapentaenoic acid on blood viscosity. Clin Hemorheol 5: 493.
Köhler HJ (1971) Untersuchungen über den Einfluß von wasserlöslichen Röntgenkontrastmitteln auf die Fließeigenschaften des Blutes. Dissertationsschrift, Frankfurt am Main.
Köhler M, Rieger H, Sievers D, Krüpe M (1980) über die Reaktion des Kreislaufs auf eine gezielte Senkung der Blutviskosität. In: Müller-Wiefei H (ed) Mikrozirkulation und Blutrheologie. Witz-strock, Baden-Baden, p 76.
Köhler S (1973) Untersuchungen über den Einfluß von Diuretika auf die Fließeigenschaften des Blutes. Dissertationsschrift, Frankfurt am Main.
Koga G (1913) Zur Therapie der Spontangangrän an den Extremitäten. Dtsch Z Chir 11: 371.
Kollär L, Fendler K, Szekeres P, Kiss T (1985) Evaluation of arvin treatment with crossover double blind study (Abstract). Clin Hemorheol 5: 744.
Konishi M, Nobuko T, Muneki S, Manubu K, Kojiro Y, Ryu N (1985) Microhemodynamic changes before and after hemodialysis (Abstract). Clin Hemorheol 5: 576.
Kontras SB, Bodenbender JB, Craenen J, Hosier DM (1970) Hyperviscosity in congenital heart disease. J Pediatr 76: 214.
Kontras SB (1972) Polycythemia and hyperviscosity syndrome in infants and children. Pediatr Clin North Am 19: 919.
Kopp WL, Beirne GJ, Burns RO (1967) Hyperviscosity syndrome in multiple myeloma. Am J Med 43: 141.
Korabelshchikova NI, Bichko MV, Rishko NV (1985) Rheological properties of the blood in stenocardia patients in the dynamics of treatment with Obsidan, Corvaton, Corinfar. Vrach Delo 4: 19.
Kottmann K (1907) über die Viskosität des Blutes. Korrespondenzbl Schweizer ärzte 5: 129.
Koul BL, Nordhas O, Sonnenfeld T, Ekeström S (1984) The effect of pentoxifylline on impaired red cell deformability following open-heart surgery. Scand J Thorac Cardiovasc Surg 18: 129.
Krepp HP, Beez M, Bock P (1984) Behandlung des akuten Hirninfarktes durch hypervolämische Hämodilutionstherapie. Klinikarzt 13: 597.
Krosch H (1959) Rheologische Untersuchungen über die Viskosität des Blutes und ihre Bedeutung für klinische Kreislaufprobleme. Habilitationsschrift, Halle/Saale.
Kuschinsky G, Lüllmann H (1970) Kurzes Lehrbuch der Pharmakologie und Toxikologie. Thieme, Stuttgart.
Kuznetsov NA, Filimonov MI, Lopukhin SY, Vasilyev VE (1983) Correction of blood rheologic properties in patients with obstructive jaundice. Khirurgiia (Mosk) 8: 96.
Kuzuya F, Osawa M, Maruyama S (1985) Effects of vinpocetine on blood viscosity and platelet aggregability. Today’s Ther Trends 3: 21.
Lakomek M, Behrens-Baumann W, Schröter W, Tillmann W (1983) Absence of increased aggregation of erythrocytes in children with diabetes mellitus (Abstract). Clin Hemorheol 3: 270.
Landgraf H, Ruppel C, Saeger-Lorenz K, Vogel C, Ehrly AM (1982) Verbesserung der Fließeigenschaften des Blutes von Patienten durch niedermolekulare Hydroxyäthylstärke (Expafusin®). Infusionsther Klin Ernahr 9: 202.
Landgraf H, Ehrly AM (1984) Hämorheologische Wirkungen hypervolämischer Hämodilution mit Dextran 40 und HAES 200 bei Patienten mit arterieller Verschlußkrankheit. In: Ehrly AM (ed) Therapie mit hämorheologisch wirksamen Substanzen. Zuckschwerdt, München, p 138.
Landgraf H, Ehrly AM (1984) Wirkungen einer Clofibrat-induzierten Senkung der Fibrinogenkon-zentration im Blut bei peripheren arteriellen Durchblutungsstörungen. In: Mahler F, Nachbur B (eds) Zerebrale Ischämie. Huber, Bern, p 277.
Landgraf H (1984) Untersuchungen über die Wirkungen von Plasmaersatzstoffen auf die Fließeigenschaften des Blutes und die Sauerstoffversorgung der Skelettmuskulatur bei chronischer peripherer arterieller Verschlußkrankheit. Habilitationsschrift, Frankfurt am Main.
Landgraf H, Ehrly AM (1985) Bedeutung und Möglichkeit der Quantifizierung der Plasmaviskosität. In: Kiesewetter H, Ehrly AM, Jung F (eds) Hämorheologische Meßmethoden. Münchner Wissenschaftliche Publikationen, München, p 35.
Landgraf H, Moschner P, Ehrly AM (1985) Hypervolemic hemodilution (HHD) in claudicants: Hemorheological changes due to infusion of plasma substitutes (Abstract). Clin Hemorheol 5: 723.
Landgraf H, Ehrly AM (1986) Verhalten des Gewebesauerstoffdruckes bei peripherer arterieller Verschlußkrankheit nach hypervolämischer Hämodilution mit verschiedenen Plasmaersatzstoffen. In: Häring R (ed) DGA — Deutsche Gesellschaft für Angiologie. Referate. 5.Gemeinsame Jahrestagung der Angiologischen Gesellschaften der Bundesrepublik Deutschland, österreichs und der Schweiz, Berlin 1985. Demeter, Gräfelfing, p 304.
Landgraf H, Ehrly AM (1987) Verhalten hämorrheologischer Parameter und des Gewebesauerstoffdruckes im Verlauf einer hypervolämischen Hämodilution bei Patienten mit arterieller Verschlußkrankheit. In: Heilmann L, Beez M (eds) Neuere klinische Aspekte zur Hämodilution (Symp Essen, 1985). Schattauer, Stuttgart, p 115.
Lang GD, Lowe GDO, Walker JJ, Forbes CD, Prentice CRM, Calder AA (1984) Blood rheology in pre-eclampsia and intrauterine growth retardation: effects of blood pressure reduction with labetalol. Br J Obstet Gynaecol 91: 438.
Langsjoen PH (1966) Blood viscosity changes in acute myocardial infarction. Postgrad Med 39: A–42.
Langsjoen PH, Immon TW (1967) Rheologie changes in myocardial infarction. Am Heart J 73: 430.
Langsjoen PH, Immon TW (1968) Hemorheologic observations in acute myocardial infarction. Angiology 19: 247.
Langsjoen PH (1973) The value of reducing blood viscosity in acute myocardial infarction. Bibl Anat 11: 180.
Lanzer G, Tilz GP (1986) Die therapeutische Blutkomponentenseparation in der klinischen Notfallmedizin. Wien Med Wochenschr 136: 134.
Larcan A, Stoltz JF (1970) Microcirculation et hémorhéologie. Masson, Paris.
Larcan A, Stoltz JF (1979) Médicaments à action hémorhéologique directe ou indirecte. Méthodes d’étude et essais de classement. Thérapie 34: 5.
Larcan A, Stoltz JF (1983) Classification et Physiopathologie du syndrome d’hyperviscosité. Journ Annu Diabetol Hotel Dieu: 179 (73 ref).
Larcan A, Stoltz JF (1983) Syndromes d’hyperviscosité sanguine — classification et comprehension physiopathologique — déductions thérapeutiques. Ann Med Interne 134: 395.
Larsson H, Valdemarsson S, Hedner P, Odeberg H (1985) Reversal of increased whole blood and plasma viscosity after treatment of hypothyreoidism in man. Acta Med Scand 217: 67.
Lawson NS, Nosanchuk JS, Oberman HA, Meyers MC (1968) Therapeutic plasmapheresis in treatment of patients with Waldenström’s macroglobulinemia. Transfusion 8: 174.
Le Devehat C, Lemoine A, Cirette B, Ramet M, Vimeux M (1980) Kinetics of variations of erythrocyte filterability and 2-3 diphosphoglycerate in diabetic patients with arteriopathy of lower limbs treated with pentoxifylline. In: Stoltz JF, Drouin P (eds) Hemorheology and diseases. Doin, Paris, p 683.
Le Devehat C, Lemoine A, Cirette B, Ramet M, Vimeux M (1980) Filterability and metabolism of erythrocytes under bencyclane in diabetic patients with macroangiopathy. Folia Angiol 28(Suppl 7): 41.
Le Devehat C, Cirette B, Lemoine A, Roux E, Ramet M (1981) Activite rheologique du cervoxan. Etude de la filtrabilité et de l’état métabolique du globule rouge chez le diabetique. Angeiologie 33: 189.
Le Devehat C, Lemoine A, Cirette B, Ramet M (1981) Pharmacological influences of pentoxifylline on red cell filterability and 2-3 diphosphoglycerate. Scand J Clin Lab Invest 41(Suppl 156): 301.
Le Devehat C, Lemoine A, Ramet M, Cirette B, Roux E, Vimeux M (1981) Study of filterability and metabolic state of red cells in diabetics on artificial pancreas. Effects on insulin activity. Abstract-Booklet 2nd Europ Conf Clin Haemorheol, London, p 12.
Le Devehat C, Lemoine A, Cirette B (1983) Activite hemorheologique du buflomédil i.v. et per os dans l’angiopathie diabétique. Angéiologie 35: 243.
Le Devehat C, Lemoine A (1985) Haemorheological changes induced by Troxerutine in patients affected by venous insufficiency of lower legs (Abstract). Clin Hemorheol 5: 740.
Le Devehat C, Lemoine A, Bertrand A (1985) Effect of good control glucose by insulin with pump on haemorheological and microcirculation parameters in diabetic patients (Abstract). Clin Hemorheol 5: 673.
Leiper JM, Lowe GDO, Anderson J, Burns P, Cohen HN, Manderson WG, Forbes CD, Barbenel JC, MacCuish AC (1984) Effects of diabetic control and biosynthetic human insulin on blood rheology in established diabetics. Diab Res 1: 27.
Leonardo G, Arpaia MR, Onza C, Del Guercio R (1984) Regarding the action of buflomedil: Haemorheological and blood chemistry aspects. Curr Ther Res 36: 1016.
Leonhardt H, Grigoleit HG, Reinhardt I (1977) Changes and relationships of erythrocyte flexibility and whole blood viscosity of normo-osmolar and hyperosmolar erythrocyte suspensions influenced by 3,7-dimethyl-l-(5-oxo-hexyl)-xanthine. Vasa 6: 316.
Leonhardt H, Grigoleit HG, Reinhardt I (1978) Auswirkungen von Zigarettenrauch und oralen Kontrazeptiva auf die Plasma-und Vollblutviskosität. Med Welt 29: 880.
Leonhardt H (1978) Mikrorheologische Untersuchungen an Gesunden mit Risikofaktoren. Habilitationsschrift, Berlin.
Lerche D, Bäumler H, Pöhlmann G, Scherf HP, Bilsing R (1983) The treatment of peripheral vascular diseases by ultraviolet blood irradiation. A hemorheological study (Abstract). Clin Hemorheol 3: 283.
Lerche D, Bäumler H, Winter G, Tourowski A, Meier W (1985) A hemorheological characterization of Rocornal® in case of peripheral circulatory diseases (Abstract). Clin Hemorheol 5: 726.
Letcher RL, Chien S, Laragh JH (1979) Changes in blood viscosity accompanying the response to prazosin in patients with essential hypertension. J Cardiovasc Pharmacol 1(Suppl 1): 8.
Levine MA, Hammack WJ, Frommeyer WB (1968) Treatment of macroglobulinemia with penicillamine. Clin Res 8: 54.
Lewis DH, Sandegård J, Kutti J, Gelin J (1972) Normovolemic hemodilution in polycythemia. Observations on capillary flow and capillary transport in skeletal muscle. In: Messmer K, Schmid Schönbein H (eds) Hemodilution. Theoretical basis and clinical application. Karger, Basel, p 133.
Lewy B (1898) Die Reibung des Blutes. Arch Ges Physiol 65: 447.
Lichtman MA, Rowe JM (1982) Hyperleukocytic leukemias: Rheological, clinical and therapeutic considerations. Blood 60: 279.
Liewendahl K, Johnsson R, Majuri H (1981) Effect of anticonvulsant drugs on red cell flexibility, adenosine triphosphatase activities and cation transport. Scand J Clin Lab Invest 41(Suppl 156): 279.
Lim C jr, Kostrzewska E, Bergentz SE, Gelin LE (1969) Rheology of human blood following treatment with Dextran-40 and Dextran-70. Bibl Anat 10: 9.
Linderkamp O, Meiselman HJ, Wu PYK, Miller FC (1981) Blood and plasma viscosity and optimal hematocrit in the normal newborn infant. Clin Hemorheol 1: 575.
Linderkamp O, Hersch S, Ozanne P, Meiselman HJ (1986) Vergleich von Methoden zur Bestimmung der Erythrozytenaggregation. In: Tillmann W, Ehrly AM (eds) Hämorheologie und Hämatologie. Münchner Wissenschaftliche Publikationen, München, p 140.
Lindmann K (1908) Klinische und experimentelle Beiträge zur pharmakologischen Beeinflussung der Blutviskosität. Dissertationsschrift, Marburg.
Lindsley H, Teller D, Noonan B, Petersen M, Mannik M (1973) Hyperviscosity syndrome in multiple myeloma. Am J Med 54: 682.
Litmanovich KY, Melnikova VN, Fregatova LM, Kargin VD, Egorova LV, Kotovshchikova MA (1985) Methods of correction of hemorheological disturbances in patients with thrombobliterating diseases of the peripheral arteries of the extremities. Vest Khir 135(7): 96.
Litwin MS, Dawidson I, Barrett J, Miller E (1981) Physiologic effect in postoperative patients of intravascular cellular aggregate dissolution caused by Dextran-40 infusion. Abstract-Booklet 2nd Europ Conf Clin Haemorheol, London, p 66.
Lommel F (1904) über die Viskosität des menschlichen Blutes bei Schwitzprozeduren. Dtsch Arch Klin Med 80: 308.
Louis J, Voisin P, Kolopp M, Vaillant G, Gaillard S, Debry G, Stoltz JF, Drouin P (1983) Lack of acute effects of insulin in vivo on hemorheological parameters in hyperglycemic diabetic patients (Abstract). Clin Hemorheol 3: 294.
Lowe GDO, Campbell AF, Meek DR, Forbes CD, Prentice CRM (1978) Subcutaneous ancrod in prevention of deep-vein thrombosis after operation for fractured neck of femur. Lancet 2: 698.
Lowe GD, Morrice JJ, Fulton A, Forbes CD, Prentice CR, Barbenel JC (1978) Subcutaneous ancrod after operation for fractured hip — A dose-ranging and feasibility study. Thromb Haemost 40: 134.
Lowe GD, Morris JJ, Forbes CD, Prentice CR, Fulton AJ, Barbenel JC (1979) Subcutaneous ancrod therapy in peripheral arterial disease: Improvement in blood viscosity and nutritional blood flow. Angiology 30: 594.
Lowe GDO, Drummond MM, Forbes CD, Barbenel JC (1980) Increased blood viscosity in young women using oral contraceptives. Am J Obstet Gynecol 137: 840.
Lowe GDO, Barbenel JC, Forbes CD (eds) (1981) Clinical aspects of blood viscosity and cell de-formability. Springer, Berlin.
Lowe GDO, Barbenel JC, Forbes CD (eds) (1981) Clinical aspects of blood viscosity and cell de-formability. Section E: Therapeutic aspects of blood rheology. Springer, Berlin, p 211.
Lowe GDO, Drummond MM, Forbes CD, Barbenel JC (1981) Occlusive arterial disease and blood rheology. In: Lowe GDO, Barbenel JC, Forbes CD (eds) Clinical aspects of blood viscosity and cell deformability. Springer, Berlin, p 133.
Lowe GDO, Dunlop DJ, Lawson DH, Pollock JG, Watt JK, Forbes CD, Prentice CRM, Drummond MM (1982) Double-blind controlled clinical trial of ancrod for ischemic rest pain of the leg. Angio-logy 33: 46.
Lowe GDO, Leiper JM, Forbes CD, Manderson WG, MacCuish AC (1982) Effects of diabetic control and biosynthetic human insulin on blood rheology in established diabetes (Abstract). Diabetologia 23: 471.
Lowe GDO (1984) Evaluation of rheological therapy by orally administered drugs. Clin Hemorheol 4: 159.
Lowe GDO (1984) Blood rheology and venous thrombosis. Clin Hemorheol 4: 571.
Lowe GDO, Trope GE, Small M, Alvarez E, Foulds WS, Forbes CD (1985) Treatment of retinal vein occlusion by viscosity reduction with stanozolol (Abstract). Clin Hemorheol 5: 691.
Lucas GS, Simms MH, Caldwell NM, Alexander SJC, Stuart J (1984) Haemorrheological effects of prostaglandin E1infusion in Raynaud’s syndrome. J Clin Pathol 37: 870.
Lukjan H, Chyzy R, Krupinski K, Bielawiec M (1985) Red cell deformability in patients with arteriosclerosis obliterans and influence of some drugs. Abstract-Booklet 4th Europ Conf Clin Haemorheol, Siena, p 70.
Lusov VA, Belousov JB, Sidelmann AA, Savenkov MP, Cholodova OE, Dudaev VA (1978) The treatment of peripheral atherosclerosis with pentoxifylline. Pharmatherapeutica 2(Suppl 1): 123.
Luther B (1983) Klinisch-experimentelle Untersuchungen zur Blutviskosität. Z Exp Chir Transplant Künstliche Organe 16: 256.
Lutz TW, Barras JP (1983) Rheological behaviour of human blood and plasma at steady flow and oscillatory flow. Vasa 12: 121.
Lyons BH (1952) Cerebral thrombosis following mercurial diuresis. Can Med Assoc J 66: 545.
MacKenzie MR, Brown E (1968) Hypervolemia in hyperviscosity syndrome of macroglobulinemia (Abstract). Clin Res 16: 122.
MacKenzie MR, Brown E, Fudenberg HH (1968) Hypervolemia in the hyperviscosity syndrome of macroglobulinemia (Abstract). J Clin Invest 47: 64a.
MacKenzie MR, Fudenberg HH (1972) Macroglobulinemia: An analysis for forty patients. Blood 39: 874.
Mackintosh T (1969) Blood viscosity in newborn infant and diagnosis and treatment of hyperviscous states. Arch Dis Child 44: 781.
Magora F, Hershko C, Aronson HB (1970) The effect of electrical sleep on the viscosity of blood. Br J Anaesth 42: 1085.
Manescalchi PG, Morini R, Pasquini G, Albanese B (1983) Sulla non correlazione fra parametri della filtrazione eritrocitaria ed altri parametri emoreologici. Ric Clin Lab 13(Suppl 3): 337.
Mann G (1980) Untersuchungen über den Einfluß verschiedener Saluretika auf die Fließeigenschaften des Blutes bei Patienten mit essentieller Hypertonie. Dissertationsschrift, Frankfurt am Main.
Manrique RV (1979) Avaliaçao clinico-laboratorial da modificaçao da flexibilidade eritrocitária in-duzida pela pentoxifilina. Rev Bras Clin Terap 8: 572.
Manrique RV, Müller R (eds) (1981) Disorders of blood flow. New therapeutic aspects. Excerpta Medica, Amsterdam.
Manrique R (1983) Blood coagulation, rheology and coronary reocclusion after local thrombolysis in acute myocardial infarction. Abstract-Booklet 13th World Congr Int Union Angiol, Rochester, Minnesota, USA.
Marazzini L, Soroldoni M, Clivati A, Simonati O, Ogliari L, Brasca F, Agosti R, Longhini E (1981) Effects of isovolumetric venesection on blood viscosity, on red cell deformability and on arterial flow velocity in chronic respiratory failure with secondary polycythemia. Respiration 42: 168.
Markson A (1936) Blood viscosity in congestive heart failure. Glasgow Med J 7: 201.
Marshall M, Reiser R (1983) Changes of blood viscosity by indirect anticoagulation (Abstract). Clin Hemorheol 3: 244.
Marshall M, Reiser R (1983) Beeinflussung der Blutviskosität durch indirekte Antikoagulation. In: Nobbe F, Rudofsky G (eds) Probleme der Vor-und Nachsorge und der Narkoseführung bei invasiver angiologischer Diagnostik und Therapie. Begutachtung arterieller und venöser Gefäßschäden. Pflaum, München, p 493.
Marshall M (1984) Beeinflussung der Hämorheologie durch oral zu verabreichende Pharmaka. In: Heilmann L, Kiesewetter H, Ernst E (eds) Klinische Rheologie und Beta-1-Blockade. Zuckschwerdt, München, p 110.
Martin P (1979) Déformabilité des globules rouges et accidents vasculaires cérébraux. Intérêt de la pentoxifylline. Gaz Méd France 86: 2585.
Martin P, Vives P (1980) Red blood cell filtration in stroke. Effect of pentoxifylline. In: Stoltz JF, Drouin P (eds) Hemorheology and diseases. Doin, Paris, p 693.
Martin P, Vives P (1980) The effect of pentoxifylline on red cell deformability in cerebrovascular accidents. Curr Med Res Opin 6: 518.
Mashiah A, Patel P, Schraibman IG, Charlesworth D (1978) Drug therapy in intermittent claudication: an objective assessment of the effects of three drugs on patients with intermittent claudication. Br J Surg 65: 342.
Materazzi M, Guerrini M, Rossi C, Cappelli R, Pecchi S, Acciavatti A, Pieragalli D, Forconi S, Di Perri T (1981) Action of buflomedil on peripheral obliterative arterial disease. A rheological and metabolic study (Abstract). Clin Hemorheol 1: 488.
Mathieu D, Coget J, Vinckier L, Devulder B, Wattel F (1985) Red blood cell deformability and hyperbaric oxygen therapy (Abstract). Clin Hemorheol 5: 625.
Mátrai A, Fendler K, Horváth L (1981) Haemorheological changes after anticoagulant therapy with a heparinoid (SP 54). Abstract-Booklet 2nd Europ Conf Clin Haemorheol, London, p 84.
Matrai A, Ernst E, Eck M (1984) Hämorheologie und CO2-Bäder (Abstract). Z Phys Med Baln Med Klim 13(Sonderheft 2): 42.
Matrai A, Ernst E, Flute PT, Dormandy JA (1984) Blood filterability in peripheral vascular disease-red cell deformability or cell sticking? Clin Hemorheol 4: 311.
Matrai A, Ernst E, Dormandy JA (1985) Erythrozytenfiltrabilität: Unterscheidung zwischen Filterokklusion und Erythrozyten-Passagezeit. In: Kiesewetter H, Ehrly AM, Jung F (eds) Hämorheologische Meßmethoden. Münchner Wissenschaftliche Publikationen, München, p 117.
Matrai A, Ernst E (1985) Pentoxifylline improves white cell rheology in claudicants. Clin Hemorheol 5: 483.
Mattassi R, Cardillo B, D’Angelo F (1985) Haemorheological and clinical effects of ozone in arterial occlusive disease (Abstract). Clin Hemorheol 5: 644.
Mayer GA (1976) Blood viscosity and oral anticoagulant therapy. Am J Clin Pathol 65: 402.
Mayesima T (1912) Klinische und experimentelle Untersuchungen über die Viskosität des Blutes. Mittig Grenzgeb Med Chir 24: 413.
McCaskey GW (1908) The viscosity of the blood; its value in clinical medicine. JAMA 51: 1653.
Mehta AB, Goldman JM, Kohner E (1984) Hyperleucocytic retinopathy in chronic granulocytic leukaemia: The role of intensive leucapheresis. Br J Haematol 56: 661.
Merchan R, Doná G (1984) Microcirculation and haemorheology studies of polyunsaturated phosphatidylcholine (EPL; Lipostabil®) in the aged. Clin Trials J 21: 517.
Merchan R, Zurita IE, Martinez JF (1985) Suloctidil: Long-term trial in the aged. Study of microcirculation, viscosity, red cell deformability, fibrinolysis and lipid fractions. Drug Res 35: 855.
Mercke CE, Kjellen E (1981) Erythrocyte deformability in patients with malignant tumours — Potential role of prostaglandins. Abstract-Booklet 2nd Europ Conf Clin Haemorheol, London, p56.
Merrill EW, Cokelet GC, Britten A, Wells RE jr (1963) Non-Newtonian rheology of human blood-Effect of fibrinogen deduced by ”subtraction ”. Circ Res 13: 48.
Merrill EW, Gilliland ER, Lee TS, Salzman EW (1966) Blood rheology: Effect of fibrinogen deduced by addition. Circ Res 18: 437.
Messmer K, Schmid-Schönbein H (eds) (1972) Hemodilution — Theoretical basis and clinical application. Karger, Basel.
Messmer K, Sunder-Plassmann L (1974) Hemodilution. Prog Surg 13: 208.
Messmer K, Schmid-Schönbein H (eds) (1975) Intentional hemodilution. Bibl Haematol 41.
Messmer K (1975) Hemodilution. Surg Clin North Am 55: 659.
Messmer K, Hammersen F (eds) (1985) Entzündung und Rheologie der Leukozyten. Karger, Basel.
Metoki H, Kanazawa T, Shibutani K, Izawa M, Soma Y, Onodera K (1979) A study on blood viscosity in CVA — The relationships between blood viscosity and duration after stroke and the effects of pentoxyphyllin. Acta Neurol Scand 60(Suppl 72): 622.
Metoki H, Kudo R, Shimanaka Y, Matsui T, Kanazawa T, Mori H, Izawa K, Shibutani K, Muraoka H, Onodera K (1983) A study on blood viscosity in cerebrovascular disease. The changes of blood viscosity during the time after stroke and the effect of Pentoxifyllin on the viscosity. Hirosaki Med J 35: 1.
Mikita J, Khan O, Dormandy JA, Cotton LT (1985) Does prostacyclin influence haemorrheology in Raynaud’s phenomenon? (Abstract). Clin Hemorheol 5: 751.
Milan R, Duric D, Trajkovic B, Radojicic B, Pekic B, Tomasevic R, Duji A (1977) Syndrome of the myeloma serum hyperviscosity treated by plasmapheresis. Med Pregl 30: 471.
Miller B, Heilmann L (1985) Haemorheological parameters during chemotherapy for breast cancer (Abstract). Clin Hemorheol 5: 625.
Miller B, Heilmann L, Callies R (1985) Hemorheological studies in mammary carcinoma. Arch Gynecol 238: 559.
Milligan DW, Davies JA (1982) The effect of iron therapy on whole blood viscosity and calf blood flow in polycythaemia (Abstract). Br J Haematol 52: 137.
Milligan DW, Tooke JE, Davies JA (1982) Effect of venesection on calf blood flow in polycythaemia. Br Med J 284: 619.
Molaro G, De Angelis V, Vettore L (1985) Effetto del dipiridamolo sui parametri emoreologici nelle sindromi sclerocitemiche e policitemiche. Ric Clin Lab 15(Suppl 1): 597.
Montagnani M, Civitelli R, Nami R, Agnusdei D, Falsini G, Conti F, Bianchini C, Liberatori P, Gennari C (1985) Effects of a calcium blocking agent (nifedipine) on red blood cell deformability in essential hypertension (Abstract). Clin Hemorheol 5: 713.
Montefusco S, Ciampitiello G, Gnasso A, Postiglione A (1984) Migliorati parametri emoreologici in pazienti iperlipidemici trattati con mucopolisaccaridi. Ric Clin Lab 14(Suppl 2): 144.
Montefusco S, Ciampittiello G, Gnasso A, Cicerano U, Postiglione A (1985) Miglioramento dei parametri emoreologici dopo terapia con mucopolisaccaridi. Ric Clin Lab 15(Suppl 1): 543.
Moratti F, Cortiana M, Taglioretti D (1983) Applicazione della filtrazione eritrocitaria nello studio della vasculopatia diabetica. Efficacia terapeutica della pentossifillina. Clin Ter 106: 19.
Moscatelli B, Marmaggi S, Traietti P, Colloca A, Fabbri M, Bologna E (1984) Blood viscosity and circulating platelets activation in polycythemic COLD patients: Effect of erythroapheresis (Abstract). Respiration 46(Suppl 1): 159.
Moser M, Klieber M, Winkler R (1985) Vergleichende Studien über den Einfluß von Diät, Bewegungs-und Jodbalneotherapie auf blutrheologische Parameter bei Diabetikern im Rahmen eines 4wöchigen Kuraufenthalts in Bad Hall. Wien Klin Wochenschr 97: 327.
Motta G, Ratto GB (1980) Osservazioni cliniche sull’azione reologica ed emodinamica di taluni far-maci attivi sul microcircolo. Minerva Med 71: 1367.
Moulopoulos SD, Zereg N (1968) La viscosité kinétique du sang. Arch Mal Coeur 61: 1156.
Mozzi E, Annoni F, Chiurazzi D, Rossi R, Pacini F, Martini A (1984) Azione del benfurodil emisuccinato (Eucilat®) su alcuni parametri emoreologici in pazienti portatori di arteriopatie ostruttive croniche periferiche. Minerva Cardioangiol 32: 141.
Mozzi E, Chiurazzi D, Spinola A, Annoni F, Germiniani R (1985) Effects of buflomedil in a group of patients with chronic peripheral arterial diseases. Clinical and hemorheological evaluation. J Int Med Res 13: 317.
Müller K, Haaß A, Jäger H, Wagner EM, Hellstern P (1983) Dextran und HAES, vergleichbare und unterschiedliche hämorheologische Parameter. Psycho 9: 381.
Müller O, Inada R (1904) Jodwirkung bei Arteriosklerose. Dtsch Med Wochenschr 30: 1751.
Müller-Bühl U, Comberg HU, Diehm C, Allenberg J, Mörl H (1982) Hämodilutions-Therapie der arteriellen Verschlußkrankheit mit Hydroxyäthylstärke 200/0,5. Münch Med Wochenschr 10: 241.
Muggeo M, Calabrò A, Businaro V, Patussi L, Volpe A, Signorini GP, Crepaldi G (1983) Blood clotting, fibrinolytic and haemorheological parameters in ischaemic vascular disease: the effects of pentoxifylline in the treatment of acute cerebral vascular disease. Pharmatherapeutica 3(Suppl 1): 74.
Murashko VV, Yusipova TA, Strutynskii AV, Dzhanashiya PK, Shenshina AM, Sklyarova MA (1984) Effect of sodium nitrite on blood rheology, microcirculation and blood coagulation in patients with circulatory failure. Ter Arkh 56(4): 108.
Nalefski LA, Gibert NC, Sheedy JA (1950) Viscosity studies on blood following the administration of anticoagulants. J Lab Clin Med 36: 970.
Nenci GG (1985) Long-term tolerability and activity on platelet aggregation and erythrocyte deformability of indobufen in cardiovascular patients. Abstract-Booklet 4th Europ Conf Clin Haemorheol, Siena, p 184.
Neumann V, Cove DH, Shapiro LM, George AJ, Kenny MW, Meakin M, Stuart J (1983) Effect of ticlopidine on platelet function and blood rheology in diabetes mellitus. Clin Hemorheol 3: 13.
Nusbacher J (1982) Therapeutic hemapheresis. Clin Lab Med 2: 87.
O’Reilly MJG, Dodds AJ, Tolpos G, Hamilton A, Cotton LT (1979) Plasmapheresis in Raynaud’s phenomenon. In: Heidrich H (ed) Raynaud’s phenomenon. TM, Bad Oeynhausen, p 291.
Orr JE, Davidson RJL, Russell IF, Robertson GS (1982) A haemorheological study of althesin. Br J Anaesth 54: 1003.
Osawa M, Maruyama S (1985) über den Einfluß von ”TCV-3B ” (Vinpocetin) auf die Blutviskosität in ischämischen zerebrovaskulären Erkrankungen. Ther Hung 33: 7.
Oski FA, Lubin B, Buchert EB (1972) Reduced red cell filterability with oral contraceptive agents. Ann Intern Med 77: 417.
Ostwald W (1924) Zur Viskosimetrie kolloidaler Lösungen. Z Physikal Chem 111: 62.
Ott M (1973) Untersuchungen über den Einfluß von Vasodilatantien auf die Blutviskosität. Dissertationsschrift, Berlin.
Ott E, Lechner H (1981) Hemorheologic conditions in patients with cerebrovascular disease altered by treatment with pentoxifylline. Ric Clin Lab 11(Suppl 1): 253.
Ott E, Lechner H (1983) Changes of flow properties of the blood in cerebrovascular disease and their medical treatment with pentoxifylline. J Cereb Blood Flow Metab 3(Suppl 1): 530.
Ott E, Lechner H (1985) The effect of budipine on the rheology of the blood. In: Gerstenbrand F, Poewe W, Stern G (eds) Clinical experiences with budipine in Parkinson therapy. Springer, Berlin, p 182.
Oughton J, Lawson P, Kohner EM, Barnes AJ (1983) The effect of improved metabolic control on diabetic complications and on blood rheology (Abstract). Clin Hemorheol 3: 270.
Paisey RB, Harkness J, Hartog M, Chadwick T (1980) The effect of improvement in diabetic control on plasma and whole blood viscosity. Diabetologia 19: 345.
Palareti G, De Fabritiis A, Poggi M, Tricarico MG, Borgatti E, Coccheri S (1981) Haemorheological parameters in essential hypertension (EH) and early changes during antihypertensive treatments (Abstract). Clin Hemorheol 1: 495.
Palareti G, Poggi M, Grauso F, Tricarico MG, Rodorigo G, Coccheri S (1982) Haemorheologic changes in women during oral contraception (Abstract). Haemostasis 12: 145.
Palareti G, Poggi M, Limoni P, Andreoli A, Tricarico MG, Coccheri S (1983) Changes in the rheologic properties of blood in acute cerebrovascular disease: Effects of treatment with 1-eburnamonine. Int Angiol 2: 179.
Parnetti L, Ciuffetti G, Mercuri M, Senin U (1985) Haemorheological pattern in initial mental deterioration: results of a long-term study using piracetam and pentoxifylline. Arch Gerontol Geriatr 4: 141.
Passero S, Bonelli G, Guerrini M, Acciavatti A, Nardini M, Battistini N (1985) Effetti del trattamento cronico con farmaci antiaggreganti sulla viscosità ematica in pazienti con malattie cerebrovascola-ri. Ric Clin Lab 15(Suppl 1): 593.
Pau P, Mereu S, Montisci R, Falchi S, Petruzzo P (1983) No changes in red cells deformability in Raynaud phenomenon induced by beta adrenoceptors stimulation (Abstract). Biorheology 20: 406.
Pavlovskii DP (1965) Effect of anticoagulants on blood viscosity, circulation time and the capillaroscopic picture. Ter Arkh 37: 367.
Pecker J, Vallée B, Haranger JM, Gueguen M (1978) Torental et accidents ischémiques du Système nerveux central. L’Ouest Méd 31: 1571.
Pennarola R, De Martino F, Barletta R, Mazzarella S, Sacco M (1983) Hemorheologic aspects among 25 cases of microangiopathy by vibrating tools treated with pentoxifylline (Abstract). Clin Hemorheol 3: 289.
Perego MA, Sergio G, Artale F (1981) Aspetti emoreologici in rapporto all fisiopatologia e alla clinica dell’arteriopatia ostruttiva periferica. Ric Clin Lab 11(Suppl 1): 281.
Perego MA, Sergio G, Artale F, Cramarossa L, Espureo M (1982) Traitement hémorhéologique des artériopathies obstructives périphériques. Angéiologie 34: 33.
Perego MA, Sergio G, Espureo M, Francisci A, Artale F (1982) Haemodynamic and haemorheological effects of buflomedil in patients with peripheral occlusive arterial disease. Curr Med Res Opin 8: 178.
Perego MA, Sergio G, Artale F (1983) Haemorheological aspects of the pathophysiology and clinical features of peripheral occlusive arterial disease. Pharmatherapeutica 3(Suppl 1): 91.
Perego MA, Sergio G, Artale F, Giunti P, Danese C (1985) Effects of physical training on regional blood filtrability and platelet β-thromboglobulin in patients with peripheral arteriopathy (Abstract). Clin Hemorheol 5: 652.
Perego MA, Sergio G, Artale F, Giunti P, Danese C (1986) Haemorrheological improvement by pentoxifylline in patients with peripheral arterial occlusive disease. Curr Med Res Opin 10: 135.
Perhoniemi V, Salmenkivi K, Sundberg S, Johnsson R, Gordin A (1984) Effects of flunarizine and pentoxifylline on walking distance and blood rheology in claudication. Angiology 35: 366.
Pernigotti L, Neirotti M, Gagliardo S, Musso M, Sclavo R, Bulla A (1985) Effetti immediati della somministrazione di eparina e di eparani (mesoglicano) su alcuni parametri emoreologici e dell’emostasi. Ric Clin Lab 15(Suppl 1): 537.
Petralito A, Miano MF, Messina S, Grimaldi LT, Malatino LS (1985) Effects of pentoxifylline on erythrocyte aggregation (Abstract). Clin Hemorheol 5: 733.
Pfeiffer M, Tilsner V (1978) Einfluß von Etofibrat auf die Plasmaviskosität bei Hyperlipoprotein-ämien. Med Klin 73: 60.
Pieragalli D, Guerrini M, Materazzi M, Ralli L, Forconi S, Di Perri T (1983) Protective effect of buflomedil against the exercise-induced haemorheological impairment of vascular patients (Abstract). Clin Hemorheol 3: 292.
Poiseuille JML (1842) Recherches expérimentales sur le mouvement des liquides dans les tubes de très petits diamètres. Compt rend 15: 1167.
Pola P, Flore R, Tondi P, Serricchio M, Dal Lago A, Fioroni G (1984) Terapia dell’iperviscosità e della ridotta deformabilità eritrocitaria nell’arteriopatico cronico: necessità dell’impiego di più farmaci. Giorn Ital Angiol 4: 31.
Pollock S, Challoner T, Thomas D, Harrison MJG (1981) The effect of venesection of red cell deformability (Abstract). Clin Hemorheol 1: 496.
Ponari O, Catamo A, Molina E, Mombelloni A, Tonelli C, Tardio S, Squeri M (1985) Effects of glycerol on some blood rheology parameters in patients with acute cerebral ischemia. Preliminary report (Abstract). Clin Hemorheol 5: 705.
Poon PYW, Dornan TL, Orde-Peckar C, Mullins R, Bron AJ, Turner RC (1982) Blood viscosity, glycaemiccontrol and retinopathy in insulin-dependent diabetes. Clin Sci 63: 211.
Porro F, Pastori P, Lanzoni M, Curti L, Fanelli M (1985) Hemorheology in acute ischemic stroke: Influence of isovolemic hemodilution (Abstract). Clin Hemorheol 5: 669.
Porro F, Pastori M, Traverso G, Lanzoni M, Pastori P (1985) Isovolemic hemodilution in advanced chronic obstructive lung disease. A preliminary hemorheologic study (Abstract). Clin Hemorheol 5: 727.
Powles R, Smith C, Kohn J, Hamilton Fairley G (1971) Method of removing abnormal protein rapidly from patients with malignant paraproteinaemias. Br Med J 3: 664.
Pre’Denning du A, Watson JH (1906) The viscosity of blood. Proc R Soc B 78: 328.
Preston FE, Cooke KB, Foster ME, Winfield DA, Lee D (1978) Myelomatosis and the hyperviscosity syndrome. Br J Haematol 38: 517.
Preston FE, Sokol RJ, Lilleyman JS, Winfield DA, Blackburn EK (1978) Cellular hyperviscosity as a cause of neurological symptoms in leukaemia. Br Med J 1: 476.
Pretolani E, Battistini G, Iosa G, Tonti D, Zoli I (1983) II ciclonicato nella terapia medica delle arteriopatieperiferiche. Giorn Ital Angiol 3: 268.
Pronk EAS, Klein F, Eikerbout F, Radema H, Cleton FJ (1969) Therapy of macroglobulinemia. Acta Med Scand 186: 273.
Pruzanski W, Watt JG (1972) Serum viscosity and hyperviscosity syndrome in IgG multiple myeloma. Ann Intern Med 77: 853.
Putnam TC, Kevy SV, Replogle RL (1967) Factors influencing the viscosity of blood. Surg Gynecol Obstet 124: 547.
Rakita L, Gillespie DG, Sancetta SM (1965) The acute and chronic effects of phlebotomy on general hemodynamics and pulmonary functions of patients with secondary polycythemia associated with pulmonary emphysema. Am Heart J 70: 466.
Randi ML, Fabris F, Crociani ME, Battocchio F, Girolami A (1985) Effects of ticlopidine on blood fibrinogen and blood viscosity in peripheral atherosclerotic disease. Drug Res 35: 1847.
Reich L, Feizi T, Winchester R, Wechsler B, Walzer P, Wright P (1973) Effects of large scale plasmapheresis performed on patients with macroglobulinemia. Proc Am Assoc Cancer Res 14: 68.
Reid HA, Chan KE, Thean PC (1963) Prolonged coagulation defect (defibrination syndrome) in malayan viper bite. Lancet 1: 621.
Reid HL, Barnes AJ, Lock PJ, Dormandy JA, Dormandy TL (1976) A simple method for measuring erythrocyte deformability. J Clin Pathol 29: 855.
Reid HL, Dormandy JA, Barnes AJ, Lock PJ, Dormandy TL (1976) Impaired red cell deformability in peripheral vascular disease. Lancet 1: 666.
Replogle RL, Meiselman HJ, Merrill EW (1967) Clinical implications of blood rheology studies. Circulation 36: 148.
Reynolds O (1883) An experimental investigation of the circumstances which determine whether the motion of water shall be direct or sinuous and the law of resistance in parallel channels. Philos Trans R Soc 174: 935.
La Ricerca in Clinica e in Laboratorio 15 (1985) (Suppl 1).
Rieger H (1976) Zur Physiologie und Pathophysiologic der Blutplättchen unter Theologischen Aspekten. Habilitationsschrift, Aachen.
Rieger H, Leyhe A, Schmid-Schönbein H, Schoop W, Schneider R, Malotta H (1977) Isovolämische Hämodilution bei peripherer arterieller Verschlußkrankheit. Konzepte, Methoden und vorläufige Ergebnisse. In: Alexander K, Cachovan M (eds) Diabetische Angiopathien. Witzstrock, Baden-Baden, p354.
Rieger H, Schoop W, Schmid-Schönbein H, Schneider R, Malotta H (1977) Isovolemic hemodilution (IHD) in peripheral vascular occlusive disease (PVOD). Concepts, methods and preliminary results. Microvasc Res 13: 267.
Rieger H, Köhler M, Schoop W, Schmid-Schönbein H, Roth FJ, Leyhe A (1979) Hemodilution (HD) in patients with ischemic skin ulcers. Klin Wochenschr 57: 1153.
Rieger H (1982) Neues in der konservativen Therapie arterieller Durchblutungsstörungen. Med Welt 33: 576.
Ritzmann SE, Coleman SL, Levin WC (1960) The effect of some mercaptanes upon a macrocryogelglobulin; modifications induced by cysteamine, penicillamine and penicillin. J Clin Invest 39: 1320.
Ritzmann SE, Thurm RH, Truax WE, Levin WC (1960) The syndrome of macroglobulinemia: Review of the literature and a report of two cases of macrocryogelglobulinemia. Arch Intern Med 105: 939.
Ritzmann SE, Daniels JC, Levin WC (1970) Paralymphomatous disease — Syndrome of macroglobulinemia. In: Leukemia-Lymphoma. Year Book Medical, Chicago, p 169.
Roba J, Roncucci R, Lambelin G (1977) Pharmacological properties of suloctidil. Acta Clin Belg 32: 3.
Rogen SA (1940) Viscosity in cardiac failure. Modification by administration of calcium gluconate. Lancet 1: 780.
Romberg E (1904) über Arteriosklerose. Verh Kongr Inn Med 21: 60.
Roncucci R, De Hertogh R, Dormandy JA, Doumont J, Gurevich V, Lambelin G, Lansen J, Rottiers R, Souridis E, Van Stalle F, Versee L (1979) Effects of long-term treatment with suloctidil on blood viscosity, erythrocyte deformability and total fibrinogen plasma levels in diabetic patients. Drug Res 29: 682.
Rose MS, Ernst E, Lee R, Hill P, Rainsbury R, Kirkham JS (1981) Effects of hydroxychloroquine on transoperative haemorheological events (Abstract). Clin Hemorheol 1: 501.
Rosenblatt G, Stokes J, Bassett DR (1965) Whole blood viscosity, hematocrit and serum lipid levels in normal subjects and patients with coronary heart disease. J Lab Clin Med 65: 202.
Rosenkrantz TS, Oh W (1982) Cerebral blood flow velocity in infants with polycythemia and hyperviscosity: Effects of partial plasma exchange transfusion with Plasmanate. J Pediatr 101: 94.
Rosenthal A, Nathan DG, Marty AT, Button LN, Miettinen OS, Nadas AS (1970) Acute hemodynamic effects of red cell volume reduction in polycythemia of cyanotic congenital heart disease. Circulation 42: 297.
Rossi C, Pastorelli M, Romeo R, Acciavatti A, Pieragalli D, Galigani C, Pecchi S, Cappelli R, Guer-rini M, Forconi S, Di Perri T (1985) Aspects of microcirculatory activity of buflomedil (Abstract). Clin Hemorheol 5: 736.
Rousselle D, Gaillard S, Voisin P, Pointel JP, Debry G, Drouin P, Stoltz JF (1980) Blood viscosity and erythrocyte filterability in diabetic patients controlled via an artificial pancreas. In: Stoltz JF, Drouin P (eds) Hemorheology and diseases. Doin, Paris, p 411.
Rudofsky G, Brock FE, Ulrich M, Nobbe F (1979) Clinical evaluation of flunarizine: Walking distance, ergometric performance and hemodynamic and biochemical effects. Angiology 30: 470.
Ruggiero HA, Castellanos H, Caprissi LF, Caprissi ES (1982) Heparin effect on blood viscosity. Clin Cardiol 5: 215.
Ryabov GA, Semenov VN, Kosyrev AB, Bunin VM, Pospelov VV, Knyazev IV, Shafransky YA, Sundukov AN (1983) The influence of haemosorption on rheology of the blood. Anesteziol Reanimatol 3: 17.
Saitta A, Castaldo M, Bonaiuto M, Di Cesare E, Barbera N, Trifiletti A, Pizzoleo MA (1983) Aspetti emoreologici ed emocoagulativi in corso di trattamento con buflomedil cloridrato. Rass Med Int 4: 549.
Sarno A, Ferrara F, Catania A, Frazzetta F, Capobianco D, Caimi G (1982) Comportamento del pattern emoreologico in soggetti con ipertensione essenziale trattati con beta-bloccanti. Clin Ter 103: 267.
Sarno A, Caimi G (1985) L’approccio farmacologico in emoreologia. Ric Clin Lab 15(Suppl 1): 479.
Sarno A, Galluzzo A, Romano A, Giordano C, Sinagra D, Botta RM, Capobianco D, Caimi G (1985) Diabetici di I tipo trattati con insulina umana: Valutazione emoreologica durante monitorag-gio con biostator. Ric Clin Lab 15(Suppl 1): 607.
Satewachin II, Iljin VN, Schestakov VA, Alexandrova NP, Rodionov SV, Danilova LM, Iljin SG (1978) The use of pentoxifylline in a combined regimen for the prevention of re-thrombosis in major blood vessels. Pharmatherapeutica 2(Suppl 1): 109.
Savi L, Dal Lago A, Serricchio M, Pola P (1979) Action du naftidrofuryl sur les viscosites sanguine et plasmatique et sur la fibrinogéenémie. La Vie Méd 4: 285.
Schäbitz J, Brema C, Teichmann W (1982) Zur Einflußnahme von Röntgenkontrastmitteln auf die Blutviskosität. Dtsch Gesundheitswesen 37: 2006.
Schäbitz J (1983) Influence of roentgenologic contrast media on blood rheology (Abstract). Clin Hemorheol 3: 306.
Schlichting K, Heidrich H (1976) Effect of isoxsuprine on blood viscosity. Vasa 5: 51.
Schmid-Schönbein GW, Engler RL (1987) No-reflow in the microcirculation. The granulocyte tragedy. In: Hartmann A, Kuschinsky W (eds) Cerebral ischemia and hemorheology. Springer, Berlin, p 464.
Schmid-Schönbein H (1970) Rheologische Eigenschaften von Erythrozyten. Habilitationsschrift, München.
Schmid-Schönbein H, Gallasch G, von Gosen J, Volger E, Klose HJ (1976) Red cell aggregation in blood flow. I. New methods of quantification. Klin Wochenschr 54: 149.
Schmid-Schönbein H, Rieger H, Hess H (1977) Quantitative Erfassung der Effekte fibrinolytischer Therapie auf das Fließverhalten des Blutes. Klin Wochenschr 55: 111.
Schmid-Schönbein H (1978) Die Erhaltung der Fließfähigkeit des Blutes durch O-(β-Hydroxy-ethyl)-rutoside. In: Voelter W, Jung G (eds) O-(β-Hydroxyethyl)-rutoside — Experimentelle und klinische Ergebnisse. Springer, Berlin, p 129.
Schmid-Schönbein H (1981) Was ist eine Mikrozirkulationsstörung bei chronisch-degenerativer Gefäßerkrankung? Arzneimittelforschung 31: 1999.
Schmid-Schönbein H, Messmer K, Rieger H (eds) (1981) Hemodilution and flow improvement. Karger, Basel.
Schmid-Schönbein H, Rieger H (1981) Isovolaemic haemodilution. In: Lowe GDO, Barbenel JC, Forbes CD (eds) Clinical aspects of blood viscosity and cell deformability. Springer, Berlin, p 211.
Schmid-Schönbein H, Malotta H, Driessen G, Kiesewetter H, Teitel P (1983) A test profile for routine laboratories in clinical haemorheology (Abstract). Clin Hemorheol 3: 555.
Schmid-Schönbein H (1985) Antithixotrope Therapie bei arteriellen Verschlußerkrankungen: Was leisten “rheologische Maßnahmen ” bei unvermindert bestehender Obliteration? Wien Med Wochenschr 135: 368.
Schmitt HJ (1977) Entwicklung und Darstellung einer Methode zur Messung der Erythrozytenaggre-gation. Dissertationsschrift, Frankfurt am Main.
Schmittner I (1974) Einfluß von 6a-Methylprednisolon und Xantinolnicotinat auf die Fließeigenschaften des Blutes. Dissertationsschrift, Frankfurt am Main.
Schneider R, Kiesewetter H (1982) Parenterale Pentoxifyllin-Applikation bei ischämischem Insult. Dtsch Med Wochenschr 107: 1674.
Schneider R, Schmid-Schönbein H, Kiesewetter H (1983) The rheological efficiency of parenteral pentoxifylline (Trental) in patients with ischemic brain lesions. Preliminary results. Eur Neurol 22(Suppl 1): 98.
Schneider R, Körber N, Brockmann M, Kiesewetter H (1986) The haemorheological treatment of lacunar strokes: Studies with pentoxifylline (Trental 400). In: Trübestein G (ed) Konservative Therapie arterieller Durchblutungsstörungen. Thieme, Stuttgart, p 321.
Schooneman F, Pointel JP, Streiff F, Gaillard S, Drouin P, Stoltz JF (1980) Study of rheological properties of blood in various pathological situations following therapeutical plasma exchange (Preliminary study). In: Stoltz JF, Drouin P (eds) Hemorheology and diseases. Doin, Paris, p 607.
Schooneman F, Gaillard S, Paulus F, Streiff F, Stoltz JF (1983) Macro-and microrheological variations observed during plasma exchange in cases of monoclonal disglobulinemia (Abstract). Clin Hemorheol 3: 335.
Schooneman F, Paulus F, Gaillard S, Streiff F, Stoltz JF (1985) Macro-and microrheological variations observed during plasma exchange in cases of monoclonal disglobulinemia. Clin Hemorheol 5: 51.
Schooneman F, Gaillard S, Paulus F, Stoltz JF, Streiff F (1985) Variations hémorhéologiques au cours de 50 dysglobulinémies monoclonales traitées par échanges plasmatiques. Rev Méd Interne 6: 487.
Schubotz R, Mühlfellner O (1977) The effect of pentoxifylline on erythrocyte deformability and on phosphatide fatty acid distribution in the erythrocyte membrane. Curr Med Res Opin 4: 609.
Schülke K, Hartel W (1966) Vergleichende Untersuchungen über das Verhalten der Plasmaviscosität und des Blutvolumens nach Gabe von hoch-und niedermolekularen Dextranen. Langenbecks Arch Klin Chir 316: 623.
Schürmann W, Eberhardt R, Pfafferott C, Volger E (1986) Zusammenhang zwischen der antiangi-nösen Wirkung und der Erythrozytenfiltrabilität und-aggregation von Nifedipin (Abstract). Z Kardiol 75(Suppl 1): 80.
Schulz CEJ, Richter W, Naujoks J (1977) Blutviskosität und Innenohrschwerhörigkeit. Laryngol Rhinol Otol (Stuttg) 56: 328.
Schwab PJ, Fahey JL (1960) Treatment of Waldenström’s macroglobulinemia by plasmapheresis. N Engl J Med 60: 574.
Schwab PJ, Fahey JL (1960) Beneficial effects of serum viscosity reduction in two patients with Waldenström’s macroglobulinemia. Clin Res 8: 55.
Schwab PJ, Okun E, Fahey JL (1960) Reversal of retinopathy in Waldenström’s macroglobulinemia by plasmapheresis. Arch Ophthalmol 64: 515.
Schwartzkopff W, Roetz R (1978) Verträglichkeit und Wirkungen von Sinteroid®. Therapiewoche 28: 2437.
Schwedoff T (1890) Recherches expérimentales sur la cohesion des liquides. J Physique Théorétique Appliquée 9: 34.
Scott Blair GW (1974) An introduction to biorheology. Elsevier Scientific, Amsterdam.
Seaman GVF, Engel R, Swank R, Hissen W (1965) Circadian periodicity in some physicochemical parameters of circulating blood. Nature 207: 833.
Segel N, Bishop JM (1966) The circulation in patients with chronic bronchitis and emphysema at rest and during exercise, with special reference to the influence of changes in blood viscosity and blood volume on the pulmonary circulation. J Clin Invest 45: 1555.
Seiffge D (1980) Methods for the investigation of drug-influence on aggregation and deformability of red blood cells (RBC). In: Stoltz JF, Drouin P (eds) Hemorheology and diseases. Doin, Paris, p 657.
Seiffge D, Berthold R, Berthold F (1983) Effect of pentoxifylline on sickle cell thalassaemia: Haemorheological and clinical results. Klin Wochenschr 61: 1159.
Selvetelia L, De Caterina M, Caso R, Amato B, Bracale G (1985) Variazioni emoreologiche ed emo-coagulative dopo piretoterapia in pazienti con arteriopatia ad impronta flogistica. Ric Clin Lab 15(Suppl 1): 571.
Sengespeik HC, Güntner M, Raz D, Linderkamp O (1984) Hämorheologische Effekte von Intralipid. In: Ehrly AM (ed) Therapie mit hämorheologisch wirksamen Substanzen. Zuckschwerdt, München, p 190.
Sergio G, Artale F, Espureo M, Francisci A, Astorre P, Perego MA (1981) Haemorheological improvement by pentoxifylline and buflomedil in patients with peripheral occlusive arterial disease (Abstract). Clin Hemorheol 1: 504.
Sgries B, Haedicke C, Altmann S, Stangel W, van den Berg E, Hartmann F (1980) Blood viscosity and peripheral blood flow in patients with polycythemia vera — The influence of therapeutic eryth-rocytopheresis. In: Stoltz JF, Drouin P (eds) Hemorheology and diseases. Doin, Paris, p 405.
Shabanov AH, Gudynskaja CJ, Komov DV (1967) Changes in blood viscosity in patients with endarteriitis obliterans. Lab Delo 12: 713.
Shanghai Cooperative Group for the study of tanshinone IIA: Therapeutic effect of sodium tanshi-none IIA sulfonate in patients with coronary heart disease. A double blind study. J Tradit Chin Med 4: 21.
Shigehiro S, Kakubari Y, Muramatsu J, Kato Y, Kawabata K, Kikawada R (1979) Casson viscosity of blood in ischemic heart disease — Decrease of casson viscosity by ticlopidine (Abstract). Biorheology 16: 494.
Shirinova MN, Goldfarb YS, Burykina IA, Makarenko ON (1983) Non specific detoxication mechanisms in the use of hemosorption for the treatment of burn toxemia and sepsis. Gematol Transfuziol 28: 32.
Siekmann U, Heilmann L, Ludwig H (1983) The use of low molecular dextran in cases with micro-circulatory disorders in pregnancy (Abstract). Clin Hemorheol 3: 273.
Siekmann U, Heilmann L (1984) Der Einsatz von Beta-Rezeptoren-Antagonisten in der Geburtshilfe: klinische und rheologische Ergebnisse mit Metoprolol. In: Heilmann L, Kiesewetter H, Ernst E (eds) Klinische Rheologie und Beta-1-Blockade. Zuckschwerdt, München, p 159.
Simons LA, Hickie JB, Balasubramaniam S (1985) On the effects of dietary n-3 fatty acids (Maxepa) on plasma lipids and lipoproteins in patients with hyperlipidaemia. Atherosclerosis 54: 75.
Sirs JA, Rampling MW, Dupont PA (1979) The effect of infusions of arvin into rabbits on blood rheology (Abstract). Microvasc Res 18: 282.
Skovborg F, Nielsen AV (1969) Variation in whole-blood and plasma viscosity in acidotic diabetics. Bibl Anat 10: 145.
Slonim A, Cristal N, Erez R, Shainkin-Kestenbaum R (1981) The effect of nifedipine, a calcium antagonist on red blood cell filterability (Abstract). Clin Hemorheol 1: 506.
Smith E, Kochwa S, Wassermann L (1965) Aggregation of IgG globulin in vivo. Am J Med 39: 35.
Smud R, Sermukslis B, Kartin D (1976) Changes in blood viscosity induced by pentoxifylline. Pharmatherapeutica 1: 229.
Solerte SB, Carnevale Schianca GP, Adamo S, Viola C, Baldi S, Sgarro V, Ferrari E (1983) Diabeticmicroangiopathy: preventive therapeutical approach with pentoxifylline (Abstract). Clin Hemorheol 3: 290.
Solerte SB, Adamo S, Viola C, Bozzetti A, Di Santi M, Ferrari E (1985) Pentoxifylline reduces microalbuminuria in microproteinuric diabetic patients (Abstract). Clin Hemorheol 5: 734.
Solerte SB, Ferrari E (1985) Diabetic retinal vascular complications and erythrocyte filtrability: results of a 2-year follow-up study with pentoxifylline. Pharmatherapeutica 4: 341.
Somer T (1966) The viscosity of blood, plasma and serum in dys-and paraproteinemias. Acta Med Scand 180 (Suppl 456).
Somer T (1975) Hyperviscosity syndrome in plasma cell dyscrasias. Adv Microcirc 6: 1.
Somer T, Ditzel J (1981) Clinical and rheological studies in a patient with hyperviscosity syndrome due to Waldenström’s macroglobulinemia. Bibl Haematol 47: 242.
Spürk P, Habbaba A, Angelkort B (1985) Improvements of blood-fluidity and walking-distance in patients under i. v.-therapy with pentoxifylline (Abstract). Clin Hemorheol 5: 731.
Staedt U, Genth KR, Gaa J, Ritz R (1986) Hämodilution bei Patienten mit akuter zerebraler Durchblutungstörung mit niedermolekularem Dextran (Dex 40) und mittelmolekularer Hydroxyethylstärke (HES 200). Therapiewoche 36: 2485.
Staedt U, Schwarz M, Bayerl JR, Tornow K, Heene DL (1986) Hämodilution bei akuter zerebraler Ischämie. Neurologischer Score und hämorheologische Parameter vor und nach 10tägiger Behandlung mit 10% Dex 40 und 10% HES 200/0,5 (II). Med Welt 37: 695.
Staedt U, Schwarz M, Heene DL (1986) Hämodilution bei akuter zerebraler Ischämie. Hämorheologische Parameter vor und während Infusion von 10% Dex 40 und 10% HES 200/0,5 (I). Med Welt 37: 660.
Stangel W, Haedicke C, Sgries B, Altmann S, van den Berg E, Hartmann F (1979) Influence of erythrocytapheresis on blood viscosity and peripheral blood flow in patients with polycythemia vera (Abstract). Symp Blood Cells Hemorheol 16: 502.
Sternitzky R, Scige K (1985) Clinical investigation of the effects of pentoxifylline in patients with severe peripheral occlusive vascular disease. Curr Med Res Opin 9: 602.
Stödter KH (1978) Einfluß von Adrevil auf die Fließeigenschaften menschlichen Blutes. Dissertationsschrift, Frankfurt am Main.
Störnier B, Kleinschmidt K, Loose D, Kremer K (1977) Rheological changes in the blood of patients with chronic arterial occlusive disease after the administration of vasoactive drugs. Curr Med Res Opin 4: 588.
Stornier B, Kleinschmidt K, Loose D, Kremer K (1978) Rheologische Veränderungen des Blutes bei chronisch arteriellen Verschlußkrankheiten durch Vasodilatantien. Dtsch Med Wochenschr 103: 694.
Störnier B, Störmer K, Kremer K (1978) Die Veränderung der Blutviskosität während der aortofemoralen Bypassoperation unter besonderer Berücksichtigung niedriger Schergeschwindigkeiten. Biorheology 15: 37.
Störmer K, Störmer B, Loose D, Engels G, Kremer K (1976) Einfluß von Kontrastmittel auf die Blutviskosität nach Katheterangiographie. Vasa 5: 239.
Stoltz JF, Drouin P, Gaillard S, Rousselle D, Vera JC, Pointel JP (1979) Variations de la viscosité sanguine de sujets diabétiques insulino-dépendants équilibrés par pancréas artificiel. Ann Biol Clin 37: 191.
Stoltz JF, Drouin P (eds) (1980) Hemorheology and diseases. Doin, Paris.
Stoltz JF, Larcan A (1980) Drugs affecting hemorheological parameters. In: Stoltz JF, Drouin P (eds) Hemorheology and diseases. Doin, Paris, p 651.
Stoltz JF, Schooneman F, Streiff F (1981) Hemorheological parameters and plasma exchanges. Abstract-Booklet 2nd Europ Conf Clin Haemorheol, London, p 107.
Stoltz JF (1981) Drugs affecting blood rheology — a review. Scand J Clin Lab Invest 41(Suppl 156): 287.
Stoltz JF (1982) Main determinants of red cell deformability. Clinical and pharmacological applications. Clin Hemorheol 2: 163.
Stoltz JF (1983) Les determinants de la rheologie sanguine: implications therapeutiques. Actua Chim Thér 10: 29.
Stoltz JF (1984) Blood rheology: etiology of hyperviscosity syndromes. Int Angiol 3: 13.
Stoltz JF (1985) Données fondamentales en hémorhéologie. II. Les syndromes d’hyperviscosité. Biomed Pharmacother 39: 282.
Stoltz JF, Schooneman F, Paulus F, Streiff F (1985) Micro-and macrorheological variations observed in 50 patients suffering from monoclonal dysglobulinemia and treated with plasma exchange procedures (Abstract). Clin Hemorheol 5: 728.
Stoltz JF (ed) (1986) Hémorhéologie et agrégation érythrocytaire. Médicates Internationales, Paris.
Strand T, Asplund K, Eriksson S, Hägg E, Lithner F, Wester PO (1984) A randomized controlled trial of hemodilution therapy in acute ischemic stroke. Stroke 15: 980.
Strano A, Davì G, Novo S, Avellone G, Pinto A (1981) Valutazione clinica degli effetti della pentossiflllina in pazienti effetti da disturbi circolatori periferici cronici. Ric Clin Lab 11(Suppl 1): 303.
Strano A, Novo S, Davì G, Avellone G, Mandalà V (1982) Effects of sorbinicate and nicotinic acid on blood viscosity, red cell deformation and platelet function. Pharmacol Res Commun 14: 639.
Strano A, Avellone G, Davi G, Mandala V, Raneli G (1983) Ticlopidine induced haemorheological changes in patients suffering from atherosclerosis obliterans of the lower limbs (Abstract). Clin Hemorheol 3: 290.
Strano A, Avellone G, Pinto A, Mandala V, Adamo L (1983) Pentoxiphylline induced haemorheological changes in patients suffering from atherosclerosis obliterans (Abstract). Clin Hemorheol 3: 291.
Strano A, Daví G, Novo S, Avellone G, Pinto A (1983) Clinical evaluation of the effects of pentoxifylline in patients with chronic peripheral circulatory disorders. Pharmatherapeutica 3(Suppl 1): 117.
Strano A, Davi G, Avellone G, Novo S, Pinto A (1984) Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs. Angiology 35: 459.
Strano A (1985) The rationale for haemorheological treatment of peripheral occlusive arterial disease (POAD) (Abstract). Clin Hemorheol 5: 755.
Strano A, Avellone G, Novo S, Fasulo S, Di Garbo V (1985) Modificazioni di alcuni parametri emoreologici indotte dal trattamento con pentossifillina in pazienti affetti da pregresso infarto del miocardio. Ric Clin Lab 15(Suppl 1): 621.
Strano A, Davì G, Avellone G, Novo S, Pinto A (1986) Double-blind, crossover study of the clinical efficacy and the haemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs. In: Trübestein G (ed) Konservative Therapie arterieller Durchblutungsstörungen. Thieme, Stuttgart, p 113.
Strauer BE, Fateh-Moghadam A, Kment A, Samtleben W, Volger E (1981) Use of plasmapheresis and immunosuppressive therapy in coronary microangiopathies. Bibl Haematol 47: 213.
Strauer BE (1983) Koronare Durchblutungsstörungen aus Theologischer Sicht. Therapiewoche 33: 841.
Strauß W (1975) Hämorheologische Wirkungen einer längerfristigen Gabe des Diuretikums Furosemid im Rahmen einer antihypertensiven Therapie. Dissertationsschrift, Frankfurt am Main.
Stuart J, Kenny MW (1981) Sickle-cell disease and vascular occlusion. In: Lowe GDO, Barbenel JC, Forbes CD (eds) Clinical aspects of blood viscosity and cell deformability. Springer, Berlin, p 109.
Stuart J, Stone PCW, Bareford D, Caldwell NM, Davies JE, Baar S (1985) Evaluation of leucocyte removal methods for studies of erythrocyte deformability. Clin Hemorheol 5: 137.
Stufano N, Sabbà C, Altomare E, Conese A, Palasciano G, Albano O (1983) Erythrocyte filtration and glycemic control in diabetes mellitus (Abstract). Clin Hemorheol 3: 322.
Sturani C, Palareti G, Poggi M, Schiavina M, Torricelli P, Papiris S (1985) Effects of pentoxifylline (Px) on cardiopulmonary hemodynamics and haemorheologic parameters at rest and during exercise in chronic cor pulmonale (Abstract). Clin Hemorheol 5: 732.
Sugai S (1972) IgA pyroglobulin, hyperviscosity syndrome and coagulation abnormality in a patient with multiple myeloma. Blood 39: 224.
Sunder-Plassmann L, Klövekorn WP, Holper K, Hase U, Messmer K (1971) The physiological significance of acutely induced hemodilution. Proceedings of the 6th European Conference on Microcirculation, Aalborg (1970). Karger, Basel, p 23.
Swank RL (1951) Changes in blood produced by fat meal and by intravenous heparin. Am J Physiol 164: 798.
Talpos G, White JM, Horrocks M, Cotton LT (1978) Plasmapheresis in Raynaud’s disease. Lancet 1: 416.
Tekeres M, Sarosi I, Juricskay I, Losoncsy H, Nagy I (1982) Effect of longterm ticlopidine therapy on the rheological properties of blood (Abstract). Haemostasis 12: 120.
Terekhov NT, Starikov AV, Kushko OV, Karpenko W (1982) Effect of hemosorption on the Theological properties of the blood and some indices of intoxication in patients with diffuse peritonitis. Klin Khir 3: 31.
Theiss W, Volger E, Wirtzfeld A, Keisel I, Blömer H (1980) Gerinnungsbefunde und Theologische Messungen bei Streptokinasebehandlung des akuten Myokardinfarktes. Klin Wochenschr 58: 607.
Thomas DJ, Du Boulay GH, Marshall J, Pearson TC, Ross Russell RW, Symon L, Wetherley-Mein G, Zilkha E (1977) Cerebral blood-flow in polycythaemia. Lancet 2: 161.
Thomas DJ, Marshall J, Ross Russell RW, Wetherley-Mein G, Du Boulay GH, Pearson TC, Symon L, Zilkha E (1977) Effect of haematocrit on cerebral blood-flow in man. Lancet 2: 941.
Thulesius O, Gjöres JE (1972) Studies on blood viscosity in chronic venous insufficiency, with regard to treatment with flavonoids. Angiologica 9: 390.
Tilsner V, Greul W (1975) Erfahrungen mit der defibrinierenden Therapie mit Arwin®. Folia Angiol 23: 407.
Toikawa H, Tsushima N, Sakakura M, Kaba M, Konishi M, Nakayama R, Yasunaga K (1985) Effect of prazosin on microcirculation system (Abstract). Clin Hemorheol 5: 577.
Toti G, Agosti R, Cherubini P, Farini P, Clivati A, Longhini E (1985) Normovolemic hemodilution in surgery (Abstract). Clin Hemorheol 5: 688.
Trevan JW (1918) The viscosity of blood. Biochem J 12: 60.
Tsyganyi AA, Karpenko W, Krishtof AN, Pritula SY (1982) The influence of plasma replacers on the rheological properties of the blood, suspension stability of the erythrocytes and microcirculation in patients operated for mitral stenosis. Anesteziol Reanimatol 4: 38.
Tuddenham EGD, Whittaker JA, Bradley J, Lilleyman JS, James DR (1974) Hyperviscosity syndrome in IgA multiple myeloma. Br J Haematol 27: 65.
Turczynski B, Znamirowska D (1985) Effect of adrenergic beta receptor blockaders on blood viscosity after their short-term use in patients with arteriosclerosis. Polski Tygodnik Lekarski (Warszawa) 40(17): 481.
Tymms DJ (1982) Improvement in blood viscosity following continuous subcutaneous insulin infusion in type 2 (non-insulin-dependent) diabetic patients (Abstract). Diabetologia 23: 207.
Uchimura I (1983) Effect of treatment on retinal circulation, platelet aggregation and blood viscosity in insulin-dependent and noninsulin-dependent diabetics. Bull Tokyo Med Dent Univ 30: 17.
Urai L, Makláry E, Kolonies I, Novák L (1983) Effect of pentoxifylline (Trental) on haemorheological factors and the circulation in peripheral occlusive arterial disease. Abstract-Booklet 13th World Congr Int Union Angiol, Rochester, Minnesota, USA.
Vakaliuk IP (1984) Efficacy of Corvaton in non-stable stenocardia. Vrach Delo 11: 18.
Van den Berg E, Haedicke C, Sgries B, Altmann S, Stangel W, Hartmann F (1980) Einfluß der Erythrozytopherese auf das Hyperviskositätssyndrom bei Polycythaemia vera — Klinik, Viskosität und arterielle Durchblutung. In: Müller-Wiefel H, Barras JP, Ehringer H, Krüger M (eds) Gefäßersatz. Witzstrock, Baden-Baden, p 119.
Van den Berg E, Haedicke C, Sgries B, Stangel W, Altmann S, Hartmann F (1983) Klinik und Therapie des Hyperviskositätssyndroms. Vasa 12(Suppl 10): 1.
Van Stalle F, Lambelin G (1981) Suloctidil: review of its effects on platelet survival time, platelet activation and blood viscosity (Abstract). Clin Hemorheol 1: 509.
Vaya A (1985) RBC deformability in patients with cerebrovascular disease. Influence of pentoxifylline and dipyridamole (Abstract). Clin Hemorheol 5: 734.
Vinazzer H (1971) Zur Wirkung von Arvin auf die Blutgerinnung. Wien Z Inn Med 52: 378.
Vittoria A, Guerrini M, Pieragalli D, Del Bigo C, Martelli G, Franchi M, Messa G, Blardi P, Galigani C, Di Perri T (1983) Azione dell’acetilsalicilato di lisina sulle alterazioni emoreologiche indotte dallo sforzo ischemico in pazienti vasculopatici. Ric Clin Lab 13(Suppl 3): 315.
Völker D, Martin M (1973) Verhalten der Blutviscosität unter Defibrase und der kombinierten Therapie mit Defibrase und Streptokinase. Verh Dtsch Ges Inn Med 79: 1338.
Völker D (1974) Rheologische Veränderungen unter oraler Langzeittherapie mit Bencyclan. Therapiewoche 24: 2901.
Völker D (1975) Rheologische Veränderungen unter der Therapie mit Defibrase. In: Martin M, Schoop W (eds) Aktuelle Probleme in der Angiologie, Bd 26; p 171.
Völker D (1976) Haemorheological investigations in patients with vascular disease undergoing treatment with pentoxifylline. Pharmatherapeutica 1: 154.
Völker D (1979) Orale Therapie mit Bencyclan. Z Allg Med 55: 182.
Völker R, Eichler K (1965) Nebenwirkungen von Diuretika auf Rheodynamik und Blutgerinnung. Dtsch Med Wochenschr 90: 2150.
Vogeler C (1973) Untersuchungen über die medikamentöse Beeinflussung der Filtrabilität des Blutes. Dissertationsschrift, Frankfurt am Main.
Voisin P, Kolopp M, Rousselle D, Gaillard S, Pointel JP, Stoltz JF, Debry G, Drouin P (1982) Influence du contrôle métabolique sur la viscosité sanguine et l’activité plaquettaire chez les diabétiques insulino-dépendants. Nouv Rev Fr Hématol 24: 187.
Vojnikovic B (1984) Hyperviscosity in whole blood, plasma and aqueous humor decreased by Doxium (calcium dobesilate) in diabetics with retinopathy and glaucoma: A double-blind controlled study. Ophthalmic Res 16: 150.
Volger E (1980) Experimentelle und klinische Untersuchungen über die Rheologie des Blutes bei kardiovaskulären Erkrankungen und deren Risikofaktoren. Habilitationsschrift, München.
Volger E (1983) Klinische Hämorheologie und Diabetes mellitus. In: Ehrly AM (ed) Klinische Hämorheologie: Eine Bestandsaufnahme. Zuckschwerdt, München, p 62.
Volger E, Theiss W (1983) Rheological consequences of systemic Streptokinase therapy in acute myocardial infarction. In: Trübestein G, Etzel F (eds) Fibrinolytische Therapie. Schattauer, Stuttgart, p 455.
Von Rhede van der Kloot EJH, Jacobs MJHM, Weber H, Lemmens HAJ (1985) Plasma filtration in patients with Raynaud’s phenomenon. Clin Hemorheol 5: 79.
Wade JPH (1983) Transport of oxygen to the brain in patients with elevated haematocrit values before and after venesection. Brain 106: 513.
Walker CHM, Mackintosh TF (1972) The treatment of hyperviscosity syndromes of the newborn with hemodilution. In: Messmer K, Schmid-Schönbein H (eds) Hemodilution — Theoretical basis and clinical application. Karger, Basel, p 271.
Walker RT, Matrai A, Dormandy JA, Flute PT (1983) Haemorheological and functional changes in intermittent claudication following plasmapheresis with Haemocell (Abstract). Clin Hemorheol 3: 338.
Walker RT, Dormandy J (1984) Plasma exchange in peripheral vascular disease. Arch Emerg Med 1(Suppl): 23.
Walker RT, Matrai A, Bogar L, Dormandy JA (1985) Serotonin and the flow properties of blood. J Cardiovasc Pharmacol 7(Suppl 7): 35.
Waller DG (1982) Whole blood viscosity following cardioselective beta-adrenoceptor blockade in hypertension. Clin Hemorheol 2: 243.
Waller D, Nicholson H, Roath S (1983) The acute effects of nifedipine on red cell deformability in angina pectoris (Abstract). Clin Hemorheol 3: 294.
Waller DG, Nicholson HP, Roath S (1984) The acute effects of nifedipine on red cell deformability in angina pectoris. Br J Clin Pharmacol 17: 133.
Waller DG, Roath OS (1986) Nifedipine and red cell deformability in angina. Clin Hemorheol 6: 275.
Wallis PJW, Skehan JD, Newland AC, Wedzicha JA, Mills PG, Empey DW (1986) Effects of erythrapheresis on pulmonary haemodynamics and oxygen transport in patients with secondary polycythaemia and cor pulmonale. Clin sci 70: 91.
Warstat T (1974) Untersuchungen über den Einfluß von niedermolekularem Dextran auf die Filtrabilität des Blutes in 8 μm-Filtern. Dissertationsschrift, Frankfurt am Main.
Wasilewski A (1962) Zur Pathophysiologic und Therapie der kardialen Dekompensation unter Berücksichtigung der Viskositätsänderung des Blutes. Med Klin 57: 599.
Watson WC (1957) Lipaemia, heparin and blood viscosity. Lancet 2: 366.
Watzek C, Wagner O, Draxler V, Gilly H, Schwarz S, Sporn P, Steinbereithner K, Zekert F (1978) Der Einfluß normovolämischer Hämodilution unter Verwendung von Hydroxyäthylstärke auf Kreislauf und Organfunktionen bei gefäßchirurgischen Eingriffen. Wien Klin Wochenschr 90: 224.
Watzlaw P (1978) Untersuchungen über den Einfluß von Actovegin und Doxium auf die Fließeigenschaften des Blutes. Dissertationsschrift, Frankfurt am Main.
Weber G (1979) Kontrolle therapeutischer Effekte im Bereich der Mikrozirkulation. In: Hild R, Spaan G (eds) Therapiekontrolle in der Angiologie. Witzstrock, Baden-Baden, p 336.
Weber G, Kreisel T, Peter S, Künzel J (1980) A double-blind placebo controlled crossover study in patients with peripheral vascular diseases, using a new capillary viscometer. Angiology 31: 1.
Weber H, von Rhede van der Kloot E, Jacobs MJ, Schmid-Schönbein H, Lemmens HAJ (1983) Plasma filtration therapy in patients with Raynaud’s phenomenon — 2. Haemorheological aspects (Abstract). Clin Hemorheol 3: 338.
Weber H, Schmid-Schönbein H, Lemmens HAJ (1985) Plasmapheresis as a treatment of Raynaudattacks: Microrheological differential diagnosis and evaluation of efficacy. Clin Hemorheol 5: 85.
Wedzicha JA, Rudd RM, Apps MCP, Cotter FE, Newland AC, Empey DW (1983) Erythrapheresis in patients with polycythaemia secondary to hypoxic lung disease. Br Med J 286: 511.
Wedzicha JA, Cotter FE, Rudd RM, Apps MCP, Newland AC, Empey DW (1984) Erythrapheresis compared with placebo apheresis in patients with polycythaemia secondary to hypoxic lung disease. Eur J Respir Dis 65: 579.
Weinberger I, Fuchs J, Rappaport M, Rotenberg Z, Joshua H, Agmon J (1985) Effect of sublingual isosorbide dinitrate and nifedipine on plasma viscosity, fibrinogen and hematocrit in patients with myocardial infarction. Abstract-Booklet Int Symp Cardiovasc Pharmacother, Geneva, Switzerland, Abstract 340.
Wells R (1970) Syndromes of hyperviscosity. N Engl J Med 283: 183.
Wells R (ed) (1973) The microcirculation in clinical medicine. Academic Press, New York.
Welsh WH (1911) Viscosity of the blood. Heart 3: 118.
West N (1984) Hyperviscosity syndrome in IgE myeloma. Br Med J 289: 1539.
Whittacker SRF, Winton FR (1933) The apparent viscosity of the blood flowing in the isolated hind-limb of the dog and its variation with corpuscular concentration. J Physiol (Lond) 78: 339.
Williams C, Rodriguez M, Llan de Rosos O, Pederson J, Rankin L, Llach F (1983) Blood viscosity (V), systemic vascular resistance (SVR) and blood pressure (BP) changes during hemodialysis (HD) (Abstract). Kidney Int 23: 165.
Wintrich H, Rudofsky G, Maier J (1983) The influence of IHD on hemodynamic and rheological parameters in patients with arterial occlusive disease (Abstract). Clin Hemorheol 3: 310.
Witte S, Anadere I, Chmiel H (1983) The influence of a gingko biloba extract on the increased vis-coelasticity of blood by complete stroke (Abstract). Clin Hemorheol 3: 291.
Wodniok M (1981) Untersuchungen über die Wirkung zweier Diuretika auf die Fließeigenschaften des Blutes bei Patienten mit essentieller Hypertonie. Dissertationsschrift, Frankfurt am Main.
Wolf RE, Alperin JB, Ritzmann SE, Levin WC (1972) IgG-K multiple myeloma with hyperviscosity syndrome — Response to plasmapheresis. Arch Intern Med 129: 114.
Wolfe JHN, Blackford HN, Waller D, Chapman MB, Prout WG (1983) Does haemodilution benefit patients with intermittent claudication? (Abstract). Clin Hemorheol 3: 310.
Wolfe JHN, Waller DG, Chapman MB, Blackford HN, Prout WG (1985) The effect of hemodilution upon patients with intermittent claudication. Surg Gynecol Obstet 160: 347.
Woodcock BE, Smith E, Lambert WH, Morris Jones W, Galloway JH, Greaves M, Preston FE (1984) Beneficial effect of fish oil on blood viscosity in peripheral vascular disease. Br Med J 288: 592.
Wrabetz-Wölke A, Altmann S, Deicher H, Stangel W (1980) Changes in whole blood and plasma viscosity after plasmapheresis in patients with hyperviscosity syndrome (Abstract). In: Stoltz JF, Drouin P (eds) Hemorheology and diseases. Doin, Paris, p 605.
Yamagata J, Shiozawa K, Shiokawa J (1980) Therapeutic plasma exchange for rheumatic disease. In: Sieberth HG (ed) Plasma exchange. Schattauer, Stuttgart, p266.
Yamaguchi H (1984) Therapeutic study of reduced red cell deformability in peripheral vascular disease (Abstract). Angio Arch 7: 51.
Yao ST, Shoemaker WC (1966) Plasma and whole blood viscosity changes in shock and after dex-tran infusion. Ann Surg 164: 973.
Yasunaga K, Kumada K, Matsuda K (1979) Coagulation studies on the patients treated with Defi-brase®, a snake venom batroxobin. Jpn Arch Int Med 26: 465.
Zederfeldt B (1965) Rheological disturbances and their treatment in clinical surgery. In: Copley AL (ed) Symposium on Biorheology. Part 4 of the Proceedings of the Fourth International Congress on Rheology, Brown University, Providence, Rhode Island, 1963. Interscience, New York, p397.
Zerefos NS, Boletis J, Stathakis C, Alexopoulos J, Xefteri E, Katsilabros N, Daikos G (1983) Successful kidneys transplantation corrects the impaired blood viscosity of chronically hemodialyzed patients (Abstract). Kidney Int 23: 298.
Zijlstra WG (1960) Syllektometrie. In: Kramer K (ed) Oxymetrie — Theorie und klinische Anwendung. Thieme, Stuttgart, p 117.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ehrly, A.M. (1989). Literaturverzeichnis. In: Therapeutische Hämorheologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71428-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-71428-3_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71429-0
Online ISBN: 978-3-642-71428-3
eBook Packages: Springer Book Archive